x



Share this page.

Calendar of Events

The SOT Calendar of Events contains upcoming activities hosted or sponsored by the Society, its groups, and other scientific societies, associations, or government agencies.
 
Reference: View past events | Annual Meeting Sites | CCT Meetings |
Meeting Sponsorship Opportunities

Submit new event to SOT


Event Type: Webinars
Organization: Compliance Global Inc
Event Title: Telemedicine and being Compliant
Event Date or Start Date: 3/28/2017
End Date: 3/28/2017
Country: UNITED STATES
State or Region: NY
Meeting Website: View more information
Additional Meeting Information: Nearly nine out of 10 family physicians say they would use telehealth to assist in treating their patients if they were compensated for it, according to a survey conducted by the Robert Graham Center for Anthem, Inc. and the American Academy of Family Physicians. Telemedicine is a $27 dollar billion industry set to grow to more than $34 billion dollars by 2020. By next year millions of new members will have access to covered telemedicine services by commercial payers. This growing line of business creates opportunities that require coders to be ready to code these services confidently, navigate the associated rules and reimbursement issues, and understand the emerging procedures associated with telemedicine. This one hour conference provides the listener with these coding insights and more! The question that I get almost all of the time is

Event Type: Webinars
Organization: AtoZ Compliance
Event Title: Understanding Design Controls (to include Adaptive Designs for Clinical Studies) - By AtoZ Compliance
Event Date or Start Date: 3/29/2017
End Date: 3/29/2017
Country: UNITED STATES
State or Region: NY
Meeting Website: View more information
Additional Meeting Information: Key Take Away : This webinar will take you through Design Controls that manufacturers require to follow a sound process to develop a medical device, with the intent of improving the probability that the device will reach an acceptable level of efficacy and safety. It will cover all aspects of the Design Control process to prevent costly compliance/regulatory errors up to and including medical device recalls. Overview : Design Controls are the processes used to design, develop, and manage medical devices that you manufacture. They are mandated by federal regulation however the regulations concerning design controls are vague in terms of the specific process steps required and the approaches that should be taken to achieve compliance should be developed. Knowing how the FDA both views and examines design controls is crucial to achieving compliance throughout the life of the medical devices you manufacture and is one of the most valuable compliance subject areas to explore. Noncompliance in design controls, which are consistently uncovered by the FDA during inspections and examinations, are concerned with the design control process that has been designed and applied and the documentation required to support each design control step. The specific sections of the regulations that apply to design controls include CFR 21 Part 820 Quality System regulation found in Sec. 820.30 and Sec. 820.40. These sections of the regulation are extremely complex and difficult to apply particularly for companies that are new to the medical device field. This webinar will explore how design controls should be designed to meet both the spirit and intent of the regulation and the needs of both the medical device itself and the organization. Also covered briefly will be an explanation of the FDA’s new guidance concerning Adaptive Designs for Medical Device Clinical Studies. Why Should You Attend : The number of medical device recalls over the past several years has almost doubled each year indicating that the FDA is increasingly looking at the medical device industry in general and how products are designed and managed in particular. Manufacturers are at significant compliance risk when their design control processes are flawed and are not carefully designed. Compliance risk has significant health and safety implications that medical device companies today can simply not ignore. In of Adaptive Designs, an adaptive design process can significantly reduce resource requirements, reduce the time to study completion, and increase the potential for study success. Areas Covered In This Webinar : An overview of the design control guidance for design controls A “drill down” through each step of the design control process An explanation and differentiation between verification and validation The Design Control Plan – its contents, functions, and uses The design control life cycle process An overview of Adaptive Design and the recently produced FDA guidance explaining it Learning Objectives : Describe the regulatory guidance concerning design controls Explain each step of the design control process Define the iterative nature of the design control process and how Define validation and verification Explain the importance of and differences between design inputs and outputs Explain how validation and verification is accomplished What is the design control plan? Explain where in the process design verification and validation occurs Explain the Life Cycle process and how it relates to design controls in general Overview the Guidance document for Adaptive Designs for medical Device Studies Define Adaptive Design State the advantages and limitations of Adaptive Design Explain when adaptive designs should be chosen Who Will Benefit : Quality Regulatory Compliance R & D Design and Development Manufacturing and Engineering Anyone involved in the Manufacture of Medical Devices that has had some exposure to the subject area and regulated environments For more information, please visit : https://www.atozcompliance.com/trainings-webinar/life-sciences/medical-devices/understanding-design-controls/charles-h-paul/300167?utm_source=ref&utm_medium=29Mar Email: support@atozcompliance.com Toll Free: +1- 844-414-1400 Tel: +1-516-900-5509 Level: Intermediate Speakers Profile : Charles H. Paul Charles H. Paul is the President of C. H. Paul Consulting, Inc. – a regulatory, training, and technical documentation consulting firm. Charles has been a regulatory consultant for over 20 years and has published numerous white papers on the subject. The firm works with both domestic and international clients designing solutions for complex training and documentation issues.

Event Type: Other Scientific Events
Organization: DIA
Event Title: 29th Annual DIA EuroMeeting 2017
Event Date or Start Date: 3/29/2017
End Date: 3/31/2017
Country: UNITED KINGDOM
State or Region:
Meeting Website: View more information
Additional Meeting Information:

The DIA EuroMeeting allows you to debate the issues across the entire drug development value chain during the conference & find solutions within the exhibition with 2,500+ other cross functional thought leaders.

You will hear the latest solutions and challenges in healthcare. You will have plenty of opportunities to network and build relationships with trend setters in e.g. the areas of regulatory science, clinical research and operations, value demonstration leads and patient advocates. The resulting knowledge transfer and lasting partnerships will reduce the burden of regulatory barriers, benefiting your business now and further down the line.

Themes such as Innovation, Globalisation and Value & Access will utilise input from top speakers from different faculties to achieve solutions that can be applied in your own real-life settings. Other themes will close with roundtable discussions with the speakers and a summary given by the theme leader. We trust that this additional new format will further strengthen the ability to develop new insights and opinions at our conferences - for your benefit.

Theme 1
Globalisation -
What are the current successes and challenges?

Theme 2
Innovation -
What are the key success factors?

Theme 3
Current Challenges in Clinical Research

Theme 4
eHealth/Big Data/Master- and Reference Data Management

Theme 5
Pharmacovigilance

Theme 6
Regulatory Science

Theme 7
Medical Devices and Combination Products

Theme 8
HTA, Value and Access

Theme 9
Information on Medicines, Medical Writing and Dossier Generation

Theme 10
Special Populations

Exhibiting Opportunities at the EuroMeeting.
We invite you to take your brand, product or message to the next level by joining an elite group of professionals who have one goal in mind: to help you reach your full potential. 2,500+ individual


Event Type: Other Scientific Events
Organization: SMi Group
Event Title: Asthma & COPD 2017
Event Date or Start Date: 3/29/2017
End Date: 3/30/2017
Country: UNITED KINGDOM
State or Region: London
Meeting Website: View more information
Additional Meeting Information: Aimed at senior scientists and respiratory and inhalation specialists, Asthma & COPD 2017 will reflect on the ongoing issues and latest developments of these two diseases. With a carefully selected panel of industry experts, the 2017 event will address the latest challenges and changes in the fields of asthma and COPD. The agenda will explore novel approaches to treatment, including cutting edge developments in triple combination therapies and phenotyping. As well as identify challenges to device development and delivery, deepen our understanding of the problems relating to these diseases, and discuss the hot topic of electronic health monitoring. Featured Speakers: Quan Yang, Pharmaceutical Assessor, MHRA Stephen Beckman, Head of Global Respiratory and Allergy, Mylan Outi Vaarala, Vice President, Head of Translational Biology, AstraZeneca Ewan Walters, Medical Director, Teva UK David Leather, Global Medical Affairs Leader, GlaxoSmithKline Stefan Leiner, Chemical-Pharmaceutical Expert, Boehringer Ingelheim Neelima Khairatkar Joshi, Senior Vice President & Head of Drug Discovery, Glenmark Pharmaceuticals Christopher Stevenson, Venture Leader COPD Interception, Janssen Marianna Alacqua, Senior Global Medical Affairs Leader of Respiratory Biologics, AstraZeneca Frank Thielmann, Operational Lead Inhalation New Solids, Novartis and many more... Exclusive highlights in 2016: Updates from the MHRA on the regulatory challenge to developing inhalation devices Overcome hurdles to the success of new devices with Boehringer Ingelheim Janssen’s innovative approaches to COPD interception Track the emerging trends in targeted treatment with biomarkers and biologics with MedImmune Real time data collection’ – an exclusive case study presentation on GSK’s pioneering ‘Salford Lung study’ WORKSHOPS: Both interactive workshops have been carefully selected to complement the topics covered in the conference agenda.

Event Type: Webinars
Organization: AtoZ Compliance
Event Title: Reinventing Remote Monitoring to Improve Clinical Trial Quality - By AtoZ Compliance
Event Date or Start Date: 3/30/2017
End Date: 3/30/2017
Country: UNITED STATES
State or Region: NY
Meeting Website: View more information
Additional Meeting Information: Key Take Away : During this webinar, strategies for remote monitoring will be discussed, including the review of data for trends, how to make the most of writing queries, and what “red flags” to look for that may indicate issues on site. Overview : Across the industry, companies are striving to find ways to improve operational efficiencies. Currently, over 80% of site-based documentation today is still fully paper based, with both cost and risk consequences for the entire clinical trial process. Specific liabilities of a paper-based system include audit and inspection risk, reduced site productivity, manual reconciliation of TMF and site records, as well as the lack of visibility into site performance. Strategies for saving time and money, without compromising oversight and quality, are an ongoing challenge within the industry. In an age where technology is ever present from ordering medications online, consulting with a physician, and having “live” conversations in chat rooms about medical issues, the clinical research industry has been slow to maximize the use of technology. Why Should You Attend : With sponsors/CROs implementing the FDA’s final guidance on a risk-based approach to monitoring, time on site is being reduced to one day visits and/or on-site visits are scheduled few and far between per monitoring plans. Better utilization of remote monitoring is critical to ensure sites are compliant and the data is accurate and consistent. Areas Covered In This Webinar : A variety of approaches can be used by sponsors to ensure monitoring obligations are fulfilled. Traditionally, this has involved on-site visits where monitors are required to check a high percentage of the data entered on the case report forms (CRF) against source, to ensure that the protocol is deployed correctly, and adverse events reported appropriately. The size, complexity and number of clinical trials mean that complete on-site monitoring is becoming an ineffective, expensive and inefficient process. However, effective monitoring is critical for the protection of subjects and the integrity of the data produced, meaning that on-site monitoring is still required by regulation for critical study parameters. Remote monitoring is seen as an acceptable addition to the process. To use remote monitoring effectively, a risk assessment must be performed and included in the monitoring plan prior to the start of any clinical program and adapted as the program evolves. Learning Objectives : Describe approaches and techniques for remote data review Explain techniques for query writing to ensure clear communication of issues Implement strategies to identify problem areas and how to maximize time on site following remote monitoring Who Will Benefit : Clinical Research Associates, Study Coordinators, Project Managers, CRA Managers, Validation specialists For more information, please visit : https://www.atozcompliance.com/trainings-webinar/life-sciences/clinical-research/remote-monitoring-to-improve-clinical-trial-quality/danielle-delucy/300183?utm_source=ref&utm_medium=30Mar Email: support@atozcompliance.com Toll Free: +1- 844-414-1400 Tel: +1-516-900-5509 Level: Beginner Speakers Profile : Danielle DeLucy Danielle DeLucy, MS, is an Independent Consultant to the Biologics and Pharmaceutical Industries. Danielle DeLucy, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations. Danielle began her QA career as a Quality Control Pharmaceutical Microbiologist at a contract laboratory where she performed various tests for their clients. In the years after, she has held positions in the Quality management arena while increasing her responsibility. She has helped to lead many Regulatory Health Inspections and was instrumental in the coaching process of her peers prior to any inspection. Currently, Danielle assists companies who are faced with warning letters, consent decrees and those wishing to improve compliance establish more robust quality systems so that the company can succeed.

Event Type: Other Scientific Events
Organization: NetZealous DBA as GlobalCompliancePanel
Event Title: Singapore Seminar on Pharmaceutical Water Systems 2017
Event Date or Start Date: 4/6/2017
End Date: 4/7/2017
Country: SINGAPORE
State or Region:
Meeting Website: View more information
Additional Meeting Information: Overview: This course is designed to provide a microbiology-focused education about all aspects of water systems and how biofilm manages to thrive there. Prior microbiological education or training, though a plus, is not a requirement because engineers and other non-biologists also need this training if they are involved with any aspect of water systems. The instructor will provide the necessary background needed to understand this very important subject matter. This understanding is essential to the proper design, validation, operation, monitoring, maintenance, troubleshooting, and excursion investigations of a high purity water system. Without this understanding, water system control consists of a set of rules that often don''t work and can cause very costly system downtime or even product recalls, and leaves the user without a clue as to what went wrong or how to effectively fix it so it doesn''t recur. Why should you attend? Much fear and hype exists with pharmaceutical biofilms, especially those in water systems. Long term biofilm control cannot be achieved from a blind set of hand-me-down rules for design and operation. One must truly understand biofilm to be able to control it. And because every water system is unique, understanding how biofilm is trying to grow in your system, which could be different than any other system. This course will give you that understanding that is translatable to any system, so that uneventful microbial control is possible. Without this understanding you will quickly find that blind rules for operation (and design) eventually fail to work, and the consequences of failure will far exceed the educational costs that could have prevented it. Speaker: Teri C. Soli, Ph.D. Principal Consultant, Soli Pharma Solutions T.C. Soli is a Ph.D. Microbiologist and President of Soli Pharma Solutions, Inc. offering training, auditing, and troubleshooting expertise covering water systems, contamination control, sterilization, aseptic processing, and microbiological laboratories. Location: Singapore Date: April 6th & 7th, 2017 and Time: 9:00 AM to 6:00 PM Venue: Mandarin Orchard Singapore Address: 333 Orchard Road, Singapore 238867 Price: Price: $1,695.00 (Seminar Fee for One Delegate) Until March 6, Early Bird Price: $1,695.00 from March 7 to April 4, Regular Price: $1,895.00 Register for 5 attendees Price: $5,085.00 $8,475.00 You Save: $3,390.00 (40%)* Quick Contact: NetZealous DBA as GlobalCompliancePanel Phone: 1-800-447-9407 Fax: 302-288-6884 Email: support@globalcompliancepanel.com Website: http://www.globalcompliancepanel.com Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900882SEMINAR?channel=mailer&camp=seminar&AdGroup=%20toxicology_april_2017_SEO Follow on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel

Event Type: Other Scientific Events
Organization: NetZealous DBA as GlobalCompliancePanel
Event Title: Water System Validation in Pharmaceuticals Industry 2017
Event Date or Start Date: 4/10/2017
End Date: 4/11/2017
Country: INDIA
State or Region: IN
Meeting Website: View more information
Additional Meeting Information: Overview: This course is designed to provide a microbiology-focused education about all aspects of water systems and how biofilm manages to thrive there. Prior microbiological education or training, though a plus, is not a requirement because engineers and other non-biologists also need this training if they are involved with any aspect of water systems. The instructor will provide the necessary background needed to understand this very important subject matter. This understanding is essential to the proper design, validation, operation, monitoring, maintenance, troubleshooting, and excursion investigations of a high purity water system. Without this understanding, water system control consists of a set of rules that often don''t work and can cause very costly system downtime or even product recalls, and leaves the user without a clue as to what went wrong or how to effectively fix it so it doesn''t recur. Why should you attend? Much fear and hype exists with pharmaceutical biofilms, especially those in water systems. Long term biofilm control cannot be achieved from a blind set of hand-me-down rules for design and operation. One must truly understand biofilm to be able to control it. And because every water system is unique, understanding how biofilm is trying to grow in your system, which could be different than any other system. This course will give you that understanding that is translatable to any system, so that uneventful microbial control is possible. Without this understanding you will quickly find that blind rules for operation (and design) eventually fail to work, and the consequences of failure will far exceed the educational costs that could have prevented it. Who will benefit: This 2-day course is particularly relevant to managers, supervisors, and operatives taking on new responsibilities related to water, but also for experienced water personnel to learn the

Event Type: Other Scientific Events
Organization: Terrapinn
Event Title: Clinical Trials Conference 2017
Event Date or Start Date: 4/10/2017
End Date: 4/12/2017
Country: UNITED STATES
State or Region: Washington, D.C.
Meeting Website: View more information
Additional Meeting Information:

As new technologies and personalized vaccines become the norm, the dynamic of clinical trials has to evolve.
This focused clinical development conference will allow you to showcase your services to those who are looking to run new trial models, need support in choosing and gaining approval for different clinical endpoints and want to understand how to get the best out of the information collected.

Clinical Trials Conference 2017 is one of the 7 different conference streams at the 17th annual World Vaccine Congress Washington. By bringing seven events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture.

Take just three days out of the office to meet over 600+ potential customers who need to find solutions to their challenges.

For more information and to register, please visit


Event Type: Other Scientific Events
Organization: Terrapinn
Event Title: Bioprocessing and Manufacturing Conference 2017
Event Date or Start Date: 4/10/2017
End Date: 4/12/2017
Country: UNITED STATES
State or Region: DC
Meeting Website: View more information
Additional Meeting Information: With new vaccine formulations and technology platforms, vaccine developers need to have the right processes in place to manufacture them during clinical trials and at commercial scale. Use this opportunity to meet with the manufacture and bioprocessing leads who need services for all of the latest manufacturing challenges, from formulating and manufacturing adjuvants, mRNA platforms, VLPs and viral vectors, to technology transfer and continuous manufacturing.

Event Type: Other Scientific Events
Organization: Terrapinn
Event Title: Influenza and Respiratory Vaccine Conference
Event Date or Start Date: 4/10/2017
End Date: 4/12/2017
Country: UNITED STATES
State or Region: DC
Meeting Website: View more information
Additional Meeting Information: This event will tackle the latest issues affecting vaccines for respiratory diseases including influenza, TB, RSV and MERS to stimulate the industry to develop more effective vaccines. Ensure you use this event to make people aware of your expertise around key topics such as universal and seasonal flu, maternal immunization and pandemic preparedness. Influenza and Respiratory Vaccine Conference is one of the 7 different conference streams at the 17th annual World Vaccine Congress Washington. By bringing seven events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture. Take just three days out of the office to meet over 600+ potential customers who need to find solutions to their challenges. For more information and to register, please visit http://goo.gl/GirnRV

Event Type: Other Scientific Events
Organization: Partnership for Clean Competition
Event Title: Partnership for Clean Competition Conference
Event Date or Start Date: 4/11/2017
End Date: 4/12/2017
Country: UNITED STATES
State or Region: NY
Meeting Website: View more information
Additional Meeting Information: The 2017 PCC conference, hosted at MLB headquarters in New York City will feature exciting updates from anti-doping scientists making innovative strides in the industry, policy discussion and athletes from both the professional leagues and Olympic movements discussing why anti-doping research is so important.

Event Type: Webinars
Organization: Compliance Global Inc
Event Title: Effective Environmental Monitoring Program: Best Practices in Bio/Pharmaceutical Production
Event Date or Start Date: 4/11/2017
End Date: 4/11/2017
Country: UNITED STATES
State or Region: NY
Meeting Website: View more information
Additional Meeting Information: Recent consent decrees have highlighted the importance that the FDA has put on environmental monitoring as a way of verifying control of the operational environment, along with the expectations when sampling methods yield positive results. Whether environmental monitoring is used simply to verify a state of cleanliness within a packaging area or during the production of sterile products, the assurance for sterility or area cleanliness is dependent not only on cleaning and sterilization methods used, but also with the control of the environment in which they are produced. The purpose of the EM program is to document the state of control of the facility, not to determine the quality of the finished product. The US Food and Drug Administration guidance document on sterile drug products (2) is very clear on this point in section X.A.I and states:

Event Type: Other Scientific Events
Organization: conference series llc
Event Title: 8th World Congress on Toxicology and Pharmacology
Event Date or Start Date: 4/13/2017
End Date: 4/15/2017
Country: UNITED ARAB EMIRATES
State or Region: Dubai
Meeting Website: View more information
Additional Meeting Information: Toxicology Congress 2017 is an amazing space for interactions on relevant topics of interest to both Toxicologists and Pharmacologists. Participants from all over the world will include scientists from industry, universities and other research and governmental institutes, and trainees in the field. It will include keynotes, workshops, oral presentations and parallel posters considering and showcasing the assessment of engaged and impactful research. The topics of the Conference will truly reflect the current and future trends in Toxicology and Pharmacology. The Congress will cover a cover a broad spectrum of toxicology and pharmacology including topics such as: Risk Assessment and Toxicology, Environmental Toxicology and Food Safety, Analytical Toxicology, Genotoxicity, Pharmacological Testing, Forensic Toxicology, Applied Pharmacology, etc., through invited keynote and plenary lectures, workshops, symposia and session talks. On behalf of the Organizing Committee we invite you to join us at Dubai on April 13, 2017, where your presence will be a key addition to enrich the meeting and set its standards high. To accomplish the same, submit you valuable research abstract to us for our Speaker Sessions and do register to the conference by following the link http://toxicology-pharmacology.conferenceseries.com/registration.php Looking forward to see you at Dubai.

Event Type: Annual Meeting
Organization: AIM Group International
Event Title: 85th EAS Congress - European Atherosclerosis Society
Event Date or Start Date: 4/23/2017
End Date: 4/26/2017
Country: CZECH REPUBLIC
State or Region:
Meeting Website: View more information
Additional Meeting Information: The historical city of Prague is a picturesque setting for the EAS Congress; its charming bridges symbolising the progress in the field as world-leading experts come together to inform and inspire. The comfortable atmosphere of the congress venue and its impressive setting will provide a unique meeting place for high-level interdisciplinary exchange. 5 Reasons to attend EAS 2017 1. A forward-looking scientific programme to excite, inspire and inform The EAS 2017 Scientific Committee has created a programme featuring ground-breaking speakers in their respective fields. 2. Share, connect and explore within our many networking opportunities EAS brings together clinicians and basic scientists across a range of disciplines, all from top-flight opinion leaders to those just starting their careers. The programme is created to give many opportunities, both formal and informal, for the personal, face-to-face discussions that spark scientific creativity, stimulate collaboration and can lead to new friendships. 3. The future of EAS – welcoming Young Investigators The future of the atherosclerosis field depends on the next generation of investigators, and at EAS 2017 we wish to encourage the participation of young scientists and clinicians by offering dedicated opportunities for them to present their work 4. Affordable registration fees EAS are proud to have affordable registration fees so that you can join us every year for this great congress. 5. The City of Prague Prague, the capital of the Czech Republic situated on both banks of the Vltava river is a beautiful city with a rich history. Thanks to its location in the centre of Europe, Prague has always been an important crossroads of trade and culture.

Event Type: Other Scientific Events
Organization: MCA Scientific Events
Event Title: World Congress on Maternal Fetal Neonatal Medicine
Event Date or Start Date: 4/23/2017
End Date: 4/26/2017
Country: UNITED KINGDOM
State or Region: London
Meeting Website: View more information
Additional Meeting Information: Relevant For: Neonatologists Perinatologists OB-GYNs Pediatricians Reasons why to attend: 1. Keen Insight on the latest trends and Innovational developments: World MFNM Congress was created to establish a congress focused on being a center for knowledge on the latest developments in the field and areas of renewed interest, on inequities of provision of care, epidemiological differences around the world and on the most challenging advances in sensitive areas. It will be also a forum for discussion on best practices related to important issues such as prematurity, non communicable diseases and environmental toxicological effects on reproduction and pregnancy 2. Learn more on the periconceptional period as far as nutrition and lifestyle are concerned: Particular emphasis will be given to the periconceptional period as far as nutrition and lifestyle are concerned. A critical appraisal of the concept of randomized trial in pregnancy looking at fetal neonatal outcomes and of personalized/individualized care in maternal infant medicine. 3. Network with leading experts from around the world on controversial developments: The 1st World Congress on Maternal Fetal Neonatal Medicine will bring together the leading experts in the field who will be discussing the latest and most controversial developments in this exciting area of medicine. 4. Know more about the dramatic environmental challenges and astonishing advances for a healthy life course 5. Experience the beautiful city of London! Sponsor/Exhibitors Package: Please email hartley@mcascientificevents.eu.

Event Type: Other Scientific Events
Organization: NetZealous DBA as GlobalCompliancePanel
Event Title: GlobalCompliancePanel is conducting a seminar on FDA Data Integrity for Computerized Systems
Event Date or Start Date: 4/24/2017
End Date: 4/25/2017
Country: SINGAPORE
State or Region:
Meeting Website: View more information
Additional Meeting Information: Overview: The Problem: We have all heard of Data Integrity but do you really understand what it is? Do you understand how 21 CFR 11 and Annex 11 fit into this picture? Specifically, can you answer questions on the following? • Evolution of 21 CFR Part 11 and Annex 11 and Why they are Back in the News • Overview and Key Requirements of Part 11 & Annex 11 • How to use a Risk Based Assessment to reduce work while still achieving Data Integrity and Compliance? • How FDA & other Regulatory Authorities Inspect Computerized Systems for Data Integrity? I often refer to 21 CFR 11 and Annex 11 as Good Software Engineering with the Documentation on Steroids! However, unless one knows how to implement Data Integrity, it is often very hard to apply requirements for DATA INTEGRITY to computerized system, and very hard to determine what needs to be done, to meet domestic and / or international regulations or business continuity requirements. In addition, the agencies have stepped up data integrity inspections and the number of citations on the subject is skyrocketing! This course is appropriate for beginner and experienced person alike. The topics will build on each other and will give you the latest trends in our heavily regulated industry and how to make it easy for yourself while still achieving data integrity. This is a very hands-on class and the attendees will be given take away templates that will enable them to build a complete package to meet Data Integrity Requirements for Computerized Systems The Seminar: This Hands-On course will provide the attendees with more detailed experience on validation / 21 CFR 11 compliance of a computer system, as well as details for activities associated with computer systems validation as follows: 1. What is Data Integrity and how is it implemented 2. How to use Risk Based Assessments to reduce work while still achieving Data Integrity and Compliance? 3. Data Integrity Frequently Asked Questions 4. Validation Master Plan 5. Risk Based Assessment 6. Complete Validation for a System (software development lifecycle) 7. Automated Test Tools 8. Infrastructure Requirements 9. Change Control 10. SOPs Who will benefit: • VP of IT • Director of IT • Quality Managers • Project Managers (for DATA INTEGRITY / IT) • Validation Specialists • Database Administrators • System Administrators • Directors / Senior Directors of Discovery • Directors / Senior Directors of Development • Directors / Senior Directors of Commercialization • Document Managers • Training Managers • Consultants • Data Managers • Safety Managers Agenda: Day 1 Schedule Day 1 Schedule Lecture 1: Introduction / Background • Introductions / Participants'' Understanding • Participants'' Objectives for the Course (Please come prepared to discuss) Lecture 2: Data Integrity • What is Data Integrity • How is it implemented • Data Integrity Frequently Asked Questions Lecture 3: 21 CFR 11 & Annex 11 • 21 CFR 11 • Annex 11 • 21 CFR 11.10(a) - Computer Systems Validation Lecture 4: Risk Assessment & Requirements • Risk Assessment for Requirements • Gathering Requirements • Entity Relationship Diagram • Process Decomposition • Exercise on how to create Requirements • SOPs Day 2 Schedule Lecture 1: Design • Design Specifications • Software Configuration and Build • Exercise on how to create Design Specifications Lecture 2: Verification & Testing • Traceability Matrix • Verification and Testing • Other Documents Lecture 3: Special Topics • Test Tools for DATA INTEGRITY • Infrastructure Requirements Lecture 4: Change Control & SOPs • Change Control Speaker: Angela Bazigos CEO, Touchstone Technologies Silicon Valley Angela Bazigos, is the CEO of Touchstone Technologies Silicon Valley, Inc.

Event Type: Other Scientific Events
Organization: Hanson Wade
Event Title: Gene Therapy for Rare Disorders 2017
Event Date or Start Date: 4/24/2017
End Date: 4/26/2017
Country: UNITED STATES
State or Region: MA
Meeting Website: View more information
Additional Meeting Information: Gene Therapy for Rare Disorders 2017 is the only conference devoted to overcoming the clinical, manufacturing, regulatory and commercialization challenges holding back progress in this field. Bringing together leading experts from innovative biotechs, large pharma, academia, regulatory authorities and key service provider companies, this conference will provide a comprehensive insight into the cutting edge progress of gene therapies combatting rare disease. Rather than replicating broad academic cell and gene therapy meetings, you will learn from in-depth case studies detailing how gene therapies can become commercially successful in ophthalmic, CNS, hepatic, muscular and many other rare disorders. Join your colleagues on this collaborative platform to accelerate the progress of the next generation of gene therapies that show improved efficacy, enhanced safety and commercial viability.

Event Type: Other Scientific Events
Organization: Conference Series LLC
Event Title: 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy
Event Date or Start Date: 4/24/2017
End Date: 7/26/2017
Country: UNITED STATES
State or Region: IL
Meeting Website: View more information
Additional Meeting Information: With the enormous response from the previous annual Tumor & Cancer Immunology conference 2016, Conference Series LLC invites all the participants from all over the world to attend 2nd International Conference on Tumor & Cancer Immunology-2017” during July 24-26, 2017 in Chicago, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. The Tumor & Cancer Immunology Conference hosting presentations from editors of prominent refereed journals, renowned and active investigators and decision makers in the field of Immunology. Tumor Immunotherapy Market Value Report Highlights:- This report provides the market analysis for various technologies and applications used for the enrichment and detection of circulating tumor cells (CTCs). Based on tumor cell detection technologies, the market is segmented into molecular methods and optical methods. Furthermore, based on the applications, the CTC prognostic technologies market is segmented into breast cancer, colorectal cancer, prostate cancer and others (lung, ovarian and pancreatic cancer). Market forecast for all these segments has been provided in the report for the period 2012 to 2020 in terms of USD million, along with CAGR for the forecast period 2014 to 2020, considering 2013 as the base year. Cancer Immunotherapy Market Value Report Highlights The world spent an all-time high of $100 billion on cancer medicines in 2014, up 33 percent from $75 billion just five years ago. Overall, global spending on cancer drugs has risen at an annual rate of 6.5 percent for the past five years, but jumped 10.3 percent in 2014, a new report by the IMS Institute for Healthcare Informatics states. The spending is concentrated in only a handful of nations. The U.S. and the five largest European countries -- Britain, France, Germany, Italy and Spain -- make up two-thirds of global spending on these medicines. The U.S. spent $42.5 billion on cancer drugs in 2014, which accounted for 11.3 percent of the nation’s total spending on all drugs.

Event Type: Other Scientific Events
Organization: Hanson Wade
Event Title: Advanced RandD Procurement in Pharma 2017
Event Date or Start Date: 4/25/2017
End Date: 4/26/2017
Country: UNITED STATES
State or Region: MA
Meeting Website: View more information
Additional Meeting Information: Advanced RandD Procurement in Pharma (April 25-26, Boston), partnered with Tamr and Univar, will gather 18+ star speakers.

Event Type: Other Scientific Events
Organization: Informa Middle East
Event Title: Pharmaceutical Regulations Summit
Event Date or Start Date: 5/1/2017
End Date: 5/4/2017
Country: UNITED ARAB EMIRATES
State or Region: Dubai
Meeting Website: View more information
Additional Meeting Information: UNDERSTANDING THE REGION'S REGULATORY FRAMEWORK FOR FASTER DRUG, COSMETIC AND DEVICE REGISTRATION APPROVAL AND MARKET ACCESS The regulatory challenges in the Middle-East and North Africa are varied and complex; they include multiple interpretations of global guidelines, lack of transparency and harmonisation in standards, as well as delayed timelines for approval. The Pharmaceutical Regulations Summit will feature government and regulatory authorities and expert insights to help you tackle and overcome these regulatory challenges, and to improve the drug, cosmetic and device approval processes for pharmaceutical, cosmeceutical, biopharmaceutical and medical device companies.

Event Type: Webinars
Organization: AtoZ Compliance
Event Title: Verification or Validation of Methods in Food Microbiology -By AtoZ Compliance
Event Date or Start Date: 5/4/2017
End Date: 5/4/2017
Country: UNITED STATES
State or Region: NY
Meeting Website: View more information
Additional Meeting Information: Key Take Away : This webinar will discuss the distinction between and requirements for method validation and method verification, to comply with ISO/IEC Standard 17025:2005 for laboratory accreditation in food/water microbiology. Overview : Method validation and method verification are two distinct procedures required to combat food bioterrorism/ comply with ISO/IEC Standard 17025:2005 for a microbiological media laboratory accreditation and microbiological contamination control in pharmaceutical clean rooms. Unfortunately, the two terms are often used interchangeably with serious consequences in bioterrorism food and FDA inspection readiness checklist. Why Should You Attend : Without a clear understanding of the different analytical approaches for verification and validation, laboratories often end up doing more unnecessary, costly work, with little benefit for FDACGMP compliance, FDA audit training, FDAGMP compliance or for FDA good documentation practices. Very often the inappropriate analytical strategy used is unacceptable to meet the requirements for FDA validation training/ accreditation and the effort needs to be repeated. Learn to do the microbiology media preparation, right the 1st time! Areas Covered In This Webinar : Quantitative and Qualitative methods have different performance measurement requirements and require different statistical analyses. Although method validation and method verification are related terms, they have very different analytical and statistical requirements particularly for compliance with ISO/IEC 17025:2005. Understanding these differences is essential for developing appropriate strategies for assessing a method’s fitness for purpose. This webinar will not only address the semantics, but will also discuss the appropriate analytical and statistical approaches to achieving successful verification and validation studies. Learning Objectives : Method performance characteristics Measuring and Monitoring Analytical competency Food Categories and Food Types Analytical requirements for Validation of Quantitative Methods Analytical requirements for Validation of Qualitative Methods Analytical requirements for Verification of Quantitative Methods Analytical requirements for Verification of Qualitative Methods Fitness for purpose Who Will Benefit : Microbiological Bench Analysts in Food, Water and Pharmaceutical Laboratories, QA Managers, Laboratory Managers/ Supervisors , QC Practitioners For more information, please visit : http://bit.ly/2kIBGom Email: support@atozcompliance.com Toll Free: +1- 844-414-1400 Tel: +1-516-900-5509 Level: Intermediate Speakers Profile : Michael Brodsky Michael has been an Environmental Microbiologist for more than 42 years. He is a Past President of the Ontario Food Protection Association (OFPA), the International Association for Food Protection (IAFP) and AOAC International. He serves as Chair for the AOAC Expert Review Committee for Microbiology, as a scientific reviewer in Microbiology for the AOAC OMA and the AOAC Research Institute, as a reviewer for Standard Method for the Examination of Water and Wastewater and as a chapter editor on QA for the Compendium of Methods in Microbiology. He is also a lead auditor/assessor in microbiology for the Canadian Association for Laboratory Accreditation (CALA) and is Vice-chair of the CALA Board of Directors.

Event Type: Other Scientific Events
Organization: SMi Group
Event Title: Pharmaceutical Freeze Drying Technology
Event Date or Start Date: 5/8/2017
End Date: 5/9/2017
Country: UNITED KINGDOM
State or Region: London
Meeting Website: View more information
Additional Meeting Information:

Bridge the gap between small scale and large scale lyophilisation production at the industry’s leading event on Pharmaceutical Freeze Drying Technology this May!

SMi are delighted to present the 5th annual event: Pharmaceutical Freeze Drying Technology 2017!

Robust capabilities in lyophilisation and freeze drying methods have become critical for process efficiency and commercial success whilst maintaining product quality and biological stability. Innovation and efficiency is requested at every level making Pharmaceutical Freeze Drying Technology the perfect platform to strengthen knowledge in key principles such as PAT and QbD, whilst staying at the forefront of technological breakthroughs to adapt to growing manufacturing demands.

Gathering a room of Senior Scientists and Heads of Pharmaceutical Engineering, the 5th annual show provides an ideal forum to discuss the latest advancements in pharmaceutical lyophilisation, welcoming regulatory guidance from the NIBSC-MHRA and expertise from the likes of Sanofi, Boehringer Ingelheim, Roche, Novo Nordisk and more!

FEATURED SPEAKERS:

• Bakul Bhatnagar, Senior Principal Scientist Bio Therapeutics R&D, Pfizer
• Sune Klint Andersen, Principal Scientist, Novo Nordisk
• Jean-René Authelin, Global Head of Pharmaceutical, Engineering, Sanofi
• Pierre Goldbach, Pharmaceutical Development & Supplies, Roche
• Paul Matejtschuk, Principle Scientist, NIBSC - MHRA
• Mahammad Ahmed, Associate Scientist II, Medimmune
• Patrick Garidel, Head of Pharmaceutical Basic Development, Boehringer Ingelheim
• Christoph Korpus, Laboratory Head, Merck
• Xiaodong Chen, Senior Research Investigator, Bristol-Myers Squibb

REASONS TO ATTEND:

• Big pharma keynotes on securing successful lyophilisation scale-up
• Innovations in freeze drying processes & technology
• Guidance on high concentration biologics
• Updates on collapsed freeze drying and spray drying as alternative approaches to conventional batch freeze drying
• New approaches to PAT and QbD principles
• Exciting insight into current and future developments in continuous manufacturing

Earlybirds available online!

Price
Conference + 2 Workshops: GBP 2697
Conference + 1 Workshop: GBP 2098
Conference: GBP 1499

Monday May 08, 2017 at 8:30 am (ends Tuesday May 09, 2017 at 5:00 pm)

Venue details
Copthorne Tara Hotel
Scarsdale Place, Kensington, London W8 5SY, United Kingdom


Event Type: Other Scientific Events
Organization: Genetic Toxicology Association
Event Title: Genetic Toxicology Association 2017 Annual Meeting
Event Date or Start Date: 5/10/2017
End Date: 5/12/2017
Country: UNITED STATES
State or Region: DE
Meeting Website: View more information
Additional Meeting Information: The Genetic Toxicology Association will hold our annual meeting from May 10th-12th in 2017 in Newark, DE. This year''s program features an array of interesting topics with a focus on applied genetic toxicology. On Wednesday May 10th, prior to our main meeting agenda, the GTA will host an ILSI-HESI Genetic Toxicology Technical Committee sponsored workshop on methods to determine the genotoxic mechanism of action in mammalian cell systems. For more information, we invite you to check out our yearly newsletter and 2017 meeting program on our website, www.gta-us.org. Abstracts are currently being accepted and must be received by March 6th for travel award eligibility. Early bird registration ends April 10th. Hope to see you there!

Event Type: Other Scientific Events
Organization: Reed Sinopharm Exhibitions
Event Title: The 77th China International Medical Equipment Fair (CMEF 2017 Spring)
Event Date or Start Date: 5/15/2017
End Date: 5/18/2017
Country: CHINA
State or Region: Shanghai
Meeting Website: View more information
Additional Meeting Information: Launched in 1979, China International Medicinal Equipment Fair (CMEF) is held twice annually in spring and autumn. After over 35 years of continuous innovation and self-improvement, CMEF has become the largest fair of medical equipment and related products and services in the Asia-Pacific region. The fair widely covers 15,000 products such as medical imaging, IVD, electronics, optics, first aid, rehabilitation, nursing, medical IT and outsourcing services, and serves the entire value chain of medical devices from the source to the end in a direct and all-round way. At each edition, nearly 4,000 medical device manufacturers from over 24 countries and approximately 120,000 people representing government procurement agencies, hospital buyers and dealers from over 100 countries and regions gather at CMEF for trade and exchanges. With an added feature of in-depth professional development, CMEF has initiated conference forums and established a series of sub-brands in the medical field including CMEF Imaging, CMEF IVD, CMEF IT and ICMD. CMEF has become the largest procurement and trade platform in the medical industry for exhibiting companies to display their corporate images and icons; it additionally serves as a professional information distribution center and platform for academic and technical exchange. ICMD: International Component Manufacturing & Design Show (ICMD) is specially designed for the business of medical device manufacturers and upstream product suppliers, which includes materials, design, R&D, components, parts, modules, software, data processing, manufacturing equipment, OEM technology, packaging, printing, cleaning, disinfecting and other related services. The Customized Medical Equipment Manufacturing Technological Innovation Forum, held concurrently with ICMD, focuses on new technologies of medical device design and the medical manufacturing industry.

Event Type: Other Scientific Events
Organization: SMi Group
Event Title: 6th Orphan Drugs and Rare Diseases Europe 2017
Event Date or Start Date: 5/15/2017
End Date: 5/16/2017
Country: GERMANY
State or Region:
Meeting Website: View more information
Additional Meeting Information: SMi''s 6th annual Orphan Drugs and Rare Diseases event will be taking place in Europe''s largest pharmaceutical market, Berlin on 15th - 16th May 2017. Rare diseases have long been under researched, with many unaware that such conditions even existed. However recent advancements within the orphan drugs landscape has resulted in a significant growth, with the market expected to reach a record breaking $191 billion by 2019. Conversely, there cannot be success without challenges. With Germany currently possessing one of the toughest pricing mechanisms and policies in Europe, this two day conference will endeavor to establish an interactive platform exploring how payers, pharma, biotech and patient organisations are preparing to participate and leverage the rapidly growing orphan drugs and rare diseases market. FEATURED SPEAKERS: Massimo Bertelli, Country Manager, Aegerion Pharmaceuticals Alastair Kent, Market Research Manager, Institute of Pharmaceutical Research and Technology Richard Porter, Chief Operating Officer, Therachon AG Peter Ramge, Senior Global Product Manager, Novo Nordisk Tony Zbeidy, General Manager Middle East and North Africa, Orphan Europe Jama Nateqi, Co-Founder, SYMPTOMA Cecile De Coster, Associate Directory, Regulatory Affairs, Alexion Pharma GmbH Carol McCudden, Patient Ambassador, ATAXIA UK CONFERENCE HIGHLIGHTS: Exchange knowledge and best practices on all relevant issues related to the rare disease environment Learn strategies on defending the pricing of orphan products and how to establish a foundation for reimbursement Hear Alexion discuss criteria, comparison and case studies for US and EU regulatory landscapes Circulate the most relevant findings within the rare disease environment to all relevant stakeholders Listen to global case studies from Aegerion and Orphan Europe Discover a new business model for developing rare diseases treatments Register at www.orphandrugs-event.com/evvnt

Event Type: Other Scientific Events
Organization: RSC / SCI / DMDG
Event Title: The 2nd Symposium on Transporters in Drug Discovery and Development
Event Date or Start Date: 5/15/2017
End Date: 5/16/2017
Country: UNITED KINGDOM
State or Region: London
Meeting Website: View more information
Additional Meeting Information: Synopsis Cell surface transporters play a key role in human health and disease, both through their impact on drug disposition and as therapeutic targets in their own right. This meeting continues on from the first, successfully held in 2014, and is anticipated to become part of a regular series. It should be of interest to medicinal chemists, DMPK scientists and other workers with interests on the impact of transporters on human health. Features of the Meeting The conference programme will cover: • Lectures on transporter structural biology, the impact of transporters on ADME and biodistribution, transporters as therapeutic targets and the toxicological impact of transporter interactions on drug development • Poster session • Related trade exhibition Call for Papers Abstracts for both oral and poster presentations are invited, and a template is available on the event website. Closing dates are: 30th November (oral) and 31st March (poster). Please download an abstract template from the website.

Event Type: Webinars
Organization: Terrapinn
Event Title: World Advanced Therapies and Regenerative Medicine Congress
Event Date or Start Date: 5/17/2017
End Date: 5/19/2017
Country: UNITED KINGDOM
State or Region:
Meeting Website: View more information
Additional Meeting Information: In May 2017 the newly named World Advanced Therapies and Regenerative Medicine Congress, will bring together 800+ attendees and explore the rapidly developing world of ATMPs (Advanced Therapy Medicinal Products). From clinical translation to commercialisation this congress will bring you the most exciting case studies and new data for stem cells, gene therapy, TCRs and gene editing. Experts in every area will help you tackle the process and regulatory hurdles of developing all new therapeutic formats all the way through manufacture and into the clinic. The event will take place alongside the co-located World Precision Medicine Congress and Cord Blood World Europe, hosting 200+ speakers, 7 tracks of content across the 3 days, enabling networking opportunities with 800+ leading industry professionals. Key topics include: . The next generation of ATMPs . Regulation, reimbursement and commercialisation for advanced therapies around the globe . CRISPR and gene editing . Stem cells as a tool for drug discovery . What''s next for cell and gene therapy, new era of regenerative medicine? . New paradigms in manufacture: gene therapy and viral vectors . Clinical development of immunotherapy and cell therapy . New frontiers in repair and replacement of diseased tissues and organs . Product, process and manufacturing development of ATMPS

Event Type: Other Scientific Events
Organization: Terrapinn
Event Title: Cord Blood World Europe 2017
Event Date or Start Date: 5/17/2017
End Date: 5/18/2017
Country: UNITED KINGDOM
State or Region:
Meeting Website: View more information
Additional Meeting Information: The 3rd annual Cord Blood World Europe event will be bringing together high level academics, clinicians and cord blood bank professionals within both the public and private sector to discuss important areas of cord blood banking and research. Sessions span from bioprocessing and collection, to the threat of haploidentical transplants, through to new exciting developments and clinical trials for new cord blood uses over the two days. As well as this, there will be roundtables, a poster zone and numerous networking opportunities – truly not an event to be missed! THE CONFERENCE Industry- and thought-leading topics bringing together the whole cord blood community Discover research being carried out on new therapeutic areas for cord blood Debate about the threats haploidentical transplants may present to the cord blood industry Hear from banks expanding into stem cell banking Conquer the issues of expansion and bioprocessing Learn more about hybrid banking models

Event Type: Other Scientific Events
Organization: International Pharmaceutical Federation
Event Title: 6th FIP Pharmaceutical Sciences World Congress 2017
Event Date or Start Date: 5/21/2017
End Date: 5/24/2017
Country: SWEDEN
State or Region: Stockholm
Meeting Website: View more information
Additional Meeting Information:

The International Pharmaceutical Federation (FIP) is pleased to bring you the 6th PSWC, in collaboration with many of the world’s leading pharmaceutical science and educational organisations.

PSWC 2017 will provide scientists from all over the world with a place to meet and network with key opinion leaders from the pharmaceutical industry, government agencies, regulatory bodies, academia and public-private partnerships, to formulate a global research agenda on "Future Medicines for One World".

Scandinavia, with Stockholm at the heart of it, will give you the best opportunity to develop a new Future for Medicines for One World.

A Young Scientists Satellite Conference (YSC) will be part of PSWC 2017. It will foster the development of a new generation of visionary and ground-breaking pharmaceutical scientists via this special event for Master students, PhD students and Post-docs to present their research.

Exhibitors and sponsors are invited to take advantage of extensive, high quality showcase opportunities, bringing the best of their products, services and organizations to the public eye. More information and varieties of exposure here: http://pswc2017.fip.org/files/static/pswc2017/6th_FIP_PSWC_2017_1_2_2016.pdf


Event Type: Other Scientific Events
Organization: SMi Group
Event Title: 17th Annual Pain Therapeutics
Event Date or Start Date: 5/22/2017
End Date: 5/23/2017
Country: UNITED KINGDOM
State or Region: London
Meeting Website: View more information
Additional Meeting Information:

Pain Therapeutics 2017 returns to London this spring, providing a focal point to discuss new clinical advancements, therapeutic developments and strategies towards minimising opioid dependency.

Created with an expert scientific advisory board, Pain Therapeutics 2017 will hone in on the latest innovations and novel approaches to pain therapy and analgesic drugs as well as look at the practicalities of using animal models and translational biomarkers in pain research.

Aimed at an audience of scientific leaders and senior specialists in neuroscience, CNS, clinical operations and pharmacology, presentations from a selection of hand-picked pharmaceutical companies currently developing novel treatments in pain, will keep attendees at the forefront of medical breakthroughs to adapt to the growing need towards minimising opioid dependency and new drug discovery.

Exclusive new findings from phase II clinical trials will be just some of the highlights at the 17th annual show when it returns to London this spring.

KEYNOTE SPEAKERS INCLUDE:

• Anthony Jones, Prof of Neuro-Rheumatology, University of Manchester
• Dr Steven Kamerling, Therapeutic Area Head for Pain, Inflammation & Oncology, Zoetis
• Dr Joseph W. Stauffer, CMO, Cara Therapeutics
• Dr Stephen Doberstein, Senior VP & CSO, Nektar Pharmaceuticals
• Dr Iain Chessell, Head of Neuroscience, AstraZeneca
• Dr Randall Stevens, CMO, Centrexion Therapeutics
• Dr Richard Butt, CEO, Apollo Therapeutics
• Prof Theo Meert, Head of Global Government Grant Office, Janssen Pharmaceutica
• Dr Narender Gavva, Scientific Director, Amgen
• Dr Thomas Christoph, Head of Pharmacology & Biomarker Development, Grunenthal
• Dr Ian Bell, Principal Scientist, MSD, USA

The agenda also features talks from Lilly UK, Novartis, Mundipharma + more!

REASONS TO ATTEND IN 2017

• New guideline on the clinical development of pain medicine
• Strategies to minimise risk of opioid dependence
• Evaluate the translation gap with case studies from a pre-clinical and clinical perspective
• Examine the use of animal models to study pain pathways
• Big Pharma updates on Neuropathic pain

Earlybird savings online

Price
Conference + 1 Workshop: GBP 2098
Conference: GBP 1499

Monday May 22, 2017 at 8:30 am (ends Tuesday May 23, 2017 at 5:00 pm)

Venue details
Copthorne Tara Hotel
Scarsdale Place, Kensington, London W8 5SY, United Kingdom


Event Type: Other Scientific Events
Organization: SMi Group
Event Title: SMi's 1st Highly Potent Active Pharmaceutical Ingredients 2017
Event Date or Start Date: 5/22/2017
End Date: 5/23/2017
Country: UNITED KINGDOM
State or Region: London
Meeting Website: View more information
Additional Meeting Information: In recent years there has been an emerging trend in the global market for Highly Potent Active Pharmaceutical Ingredients, which is largely driven by its major use in oncology for cancer treatment and more often in the form of anti-drug conjugates (ADCs). With this continued development, SMi has been receptive to the steadily increasing market growth and have launched its first Highly Potent Active Pharmaceutical Ingredients conference, set to take place 22nd – 23rd May in London, UK. The conference programme has been produced to enable delegates to gain knowledgeable insight on how to develop highly potent APIs more efficiently, safely and more cost effectively than before. Whether your area of expertise is in process development, scale up, occupational safety or outsourcing, this two day conference is certain to equip you with a wealth of actionable insights. FEATURED SPEAKERS: Alessandro Brigo, Toxicology Project Leader, Pharmaceutical Sciences Andreas Flueckiger, Chief Occupational Health Officer, Roche Gwydion Churchill, Associate Director of Chemistry, Antibiotics Business Unit, AstraZeneca Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Hungary Jack Brown, Senior Principal Scientist, Boehringer Ingelheim James Evans, Vice President CMC, NuCana BioMed Jason Hamm, Director of Chemical Development Operations, Bristol-Myers Squibb Richard Denk, Head Sales Containment, SKAN AG CONFERENCE HIGHLIGHTS Address the challenges of working with HPAPIs and approaches to scale-up Discuss strategies for CMO selection and solutions to better communication and transfer Hear about Teva API’s Operational Excellence and QC Lab Transformation Gain insight into the ISPE contamination Manual covering containment issues from the PDE/ OEL to life cycle Learn about Health Hazard Assessment Classifications and the toxicological criteria of potent compounds

Event Type: Other Scientific Events
Organization: ExL Events
Event Title: Data Integrity for Clinical Research Summit
Event Date or Start Date: 5/22/2017
End Date: 5/23/2017
Country: UNITED STATES
State or Region: NJ
Meeting Website: View more information
Additional Meeting Information: ExL Events’ Data Integrity for Clinical Research Summit, taking place on May 22-23, 2017 at the Hyatt Regency Morristown in Morristown, NJ, will feature 14 educational sessions and panels from leading industry professionals showcasing data integrity successes and challenges. Over the course of two days, attendees will closely examine current trends and the future direction of data integrity, and have the opportunity to network with industry thought leaders and peers from other organizations.

Event Type: Other Scientific Events
Organization: ExL Events
Event Title: 3rd European Clinical Trials Inspection Readiness Summit
Event Date or Start Date: 5/22/2017
End Date: 5/23/2017
Country: UNITED KINGDOM
State or Region: London
Meeting Website: View more information
Additional Meeting Information: An inspection from the FDA can pop up at any time throughout a clinical trial pipeline, and being prepared is key. The industry must move toward innovative methods and utilize new technologies to ensure compliance in a global environment. Change your inspection readiness strategy into one that is proactive and preventative, instead of one that is mainly concerned with putting out fires. Developing effective strategies for risk management through careful vendor selection and oversight, expert knowledge of FDA guidances, budget management, and TMF and pharmacovigilance audits will put your organization ahead of the pack. The 3rd European Clinical Trials Inspection Readiness Summit is designed to explore best practices for developing and maintaining compliance at clinical trial inspection sites. Delegates will leave the event armed with strategies regarding partner oversight, metrics, data quality, TMFs and risk assessment tools. Additionally, this event will provide opportunities for sharing best practices and networking across all contributors and stakeholders, including sponsors, regulators, CROs and project teams. Top 5 Reasons to Attend for 2017: 1. Review crucial information and analyze regulations from around the world, with a focus on FDA, EMA, PMDA and MHRA regulations 2.Benchmark the success of your clinical trial using metrics that measure the performance of CROs and trial sites 3. Learn strategies for ensuring there is a comprehensive clinical trial storyboard so inspectors can recreate the trial 4. Leverage process maps that can be applied to streamline TMF management and the key team members who need to be involved 5. Innovate your inspection readiness SOPs to arm them with information on risk-based modeling for inspection readiness

Event Type: Other Scientific Events
Organization: Graviton International
Event Title: Pharmacovigilance Europe Congress 2017
Event Date or Start Date: 5/24/2017
End Date: 5/25/2017
Country: UNITED KINGDOM
State or Region: London
Meeting Website: View more information
Additional Meeting Information: Pharmacovigilance Europe Congress 2017 attracts senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies. Delegates includes VPs, Directors, Heads, Managers, Scientific Advisors, Consultants, Senior scientists and professionals with intermediate to advance knowledge and experience in the following: Pharmacovigilance Risk management Drug safety Pharmacoepidemiology Drug Research and Development Clinical Pharmacology Clinical Safety Information and Clinical Data Management Medical product safety assessment Clinical research and safety Data analysis Information technology Medical information Health outcomes Sales and Marketing Clinical Trials and CRO’s Contract Manufacturing CPD International Accredited Event. 12 CPD Credits Approved.

Event Type: Other Scientific Events
Organization: Health Canada-HESI-McGill University
Event Title: Advances and Roadblocks for Use of Genomics Data in Cancer Risk Assessment for Drugs and Chemicals
Event Date or Start Date: 5/25/2017
End Date: 5/26/2017
Country: CANADA
State or Region:
Meeting Website: View more information
Additional Meeting Information: This workshop is organized by Health Canada, the Health and Environmental Sciences Institute (HESI) Application of Genomics to Mechanism-Based Risk Assessment Committee, and McGill University, and will feature multi-sector and international perspectives on current and potential applications of genomics in cancer risk assessment. The workshop will specifically address: • Areas in the current cancer risk assessment paradigm where genomics approaches will have a chance to add value in the future • Insights gained through genomics data or molecular approaches • Roadblocks for implementation of genomics in cancer risk assessment • Formulation of recommendations and next steps needed to implement genomics approaches in cancer risk assessment

Event Type: Other Scientific Events
Organization: NetZealous DBA as GlobalCompliancePanel
Event Title: Applied Statistics for Scientists and Engineers 2017
Event Date or Start Date: 5/25/2017
End Date: 5/26/2017
Country: UNITED STATES
State or Region: PA
Meeting Website: View more information
Additional Meeting Information:

Event Type: Other Scientific Events
Organization: Conference Series LLC
Event Title: International Conference and Exhibition on Nanomedicine and Drug Delivery May 29-31, 2017 Osaka, Japan
Event Date or Start Date: 5/29/2017
End Date: 5/31/2017
Country: JAPAN
State or Region:
Meeting Website: View more information
Additional Meeting Information: ConferenceSeries LLC is a renowned organization that organizes highly notable Pharmaceutical Industry Conferences throughout the globe. Currently we are bringing forth “International Conference and exhibition on Nanomedicine and Drug Delivery” scheduled to be held during May 29-31, 2017 at Osaka, Japan. NanoDelivery 2017 is expecting more than 300+ participants from across the globe with quality keynote speakers + plenary talks + posters and many more.This conference seeks to showcase work in the area of Nanomedicine, Drug Delivery Systems, and nanotechnology, Nanobiothechnology, particularly related to drug delivery. Riley Matthews Nanodelivery 2017 Japan Program Manager nanodelivery@conferenceseries.net

Event Type: Other Scientific Events
Organization: KNect365 Life Sciences
Event Title: Next Generation Protein Therapeutics Conference, San Diego
Event Date or Start Date: 6/5/2017
End Date: 6/7/2017
Country: UNITED STATES
State or Region: CA
Meeting Website: View more information
Additional Meeting Information:

Now in its 12th year, Next Generation Protein Therapeutics Summit has continued to be the industry’s most comprehensive conference for sharing new ideas to accelerate the discovery, engineering, and development of alternative scaffolds and novel protein therapeutics to create differentiated drugs.

New for 2017, we have added a more unique and in-depth focus on the chemistry, tools, techniques, methods, and strategies being applied to develop the next generation of ADCs and emerging bioconjugates for an ever-increasing number of targets. Going beyond just ADCs, we cover the latest research and innovations across all topics within bioconjugates including ADCs, bispecific conjugations, nanoparticle conjugations, and more.

Gain first-hand knowledge from world-renowned academics and industry visionaries on their latest breakthroughs to:
- Improve half-life extension, potency, selectivity, and developability through creative engineering and design approaches
- Create new pathways for the development, translation, and delivery of immunotherapies
- Develop next generation bispecifics with superior manufacturability, stability and payload capabilities
- Design applications beyond cancer for a number of major human diseases
- Utilize toll-like receptors, ion channels, and GCPRs that provide breakthrough solutions far beyond standard biologics

Event Highlights include:
- Share ideas, state-of-the-art advances, best practices, and clinical updates with 200+ world-renowned industry visionaries and academics
- 45+ New Data and Case Study Presentations
- 10+ Networking Opportunities
- 6 Concurrent Technology Workshops
- 9 Moderated Luncheon Discussions

Co-locating Next Gen Protein Therapeutics Summit with Cell Line Development & Engineering in 2017 will bring everyone together to share ideas, breakthroughs and best practices through multiple learning and networking formats, fostering a productive dialogue in a collaborative, open forum.


Event Type: Other Scientific Events
Organization: SMi Group
Event Title: Pre-Filled Syringes West Coast
Event Date or Start Date: 6/5/2017
End Date: 6/6/2017
Country: UNITED STATES
State or Region: CA
Meeting Website: View more information
Additional Meeting Information:

SMi Group are thrilled to announce the return of Pre-Filled Syringes West Coast 2017 which arrives to California on June 5-6.

Pre-Filled Syringes West Coast will gather a global audience of medical device experts and PFS industry leaders to discuss new developments and showcase cutting edge advancements, keeping you at the forefront of a booming industry.

The competitive PFS market has sparked great improvements as devices strive for higher quality, safety, and patient satisfaction. Innovation and excellence is requested at every level making Pre-Filled Syringes West Coast the perfect platform to strengthen knowledge in key principles such as human factor engineering, manufacturing and complex biologics, whilst honing in on emerging trends for parenteral devices, including auto injectors, pens, pumps and smart devices.

Notable speakers include:

- John Smith, Dir, Global Regulatory Affairs, Allergan
- Anand Subramony, VP Drug Delivery & Device Development, MedImmune
- Benir Ruano, VP, Global Manufacturing & Technical Operations, Xeris Pharmaceuticals
- Ron Forster, Executive Dir, Amgen
- Sara McNew, Dir, Human Factors & Industrial Design, Eli Lilly
- Alasdair Young, Device Engineer, Genentech
- Lori de los Reyes, Global Regulatory Affairs, Amgen
- Aaron Chesterman, Principal Engineer, Device Development, Genentech
- Tina Rees, Associate Dir – Human Factors, Ferring
- Monica de Bardi, Postdoctoral Researcher, Roche

We will also be welcoming expertise from the likes of Nemera, Nipro PharmaPackaging, Terumo, Worrell, Zeon + more!

Reasons to sign up:

- Harness global compliance requirements for product safety and risk analysis
- Assess data bridging and risk based control strategies for combination products
- Map the importance of Human factors and patient centricity in device design
- Cutting edge insight on silicone free devices, virtual reality and laser cutting in the design and manufacture of prefilled devices

Earlybirds online!


Event Type: Other Scientific Events
Organization: SMi Group
Event Title: Pharmaceutical Microbiology USA
Event Date or Start Date: 6/8/2017
End Date: 6/9/2017
Country: UNITED STATES
State or Region: California
Meeting Website: View more information
Additional Meeting Information: The seventh in its series, this event will take place in San Diego, on the 8th and 9th June 2017. Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology USA 2017 will address the current challenges and developing trends of the pharmaceutical microbiology field. Through a series of presentations from handpicked industry experts, two pre-conference workshops and an additional interactive training session, the agenda will discuss hot topics such as rapid microbiology methods (RMM), risk assessment, challenges in endotoxin recovery, environmental monitoring, sterility assurance, data integrity and much more... Exclusive highlights in 2017: - Discuss the challenges involved with microbial control with Takeda - Following the path to efficient sterility assurance with GSK - Bimeda highlight the importance of environmental modelling - Delve into the latest developments in rapid microbial methods with Janssen - Hear the latest on data integrity and compliance with Roche - Take part in an interactive extended training session with Microrite

Event Type: Other Scientific Events
Organization: GlobalCompliancePanel
Event Title: Implementation in Cosmetics Products - 2017
Event Date or Start Date: 6/8/2017
End Date: 6/9/2017
Country: SWITZERLAND
State or Region: Zurich
Meeting Website: View more information
Additional Meeting Information: Overview: Since July 2013, Regulation (EC) No 1223/2009 on Cosmetic Products of the EU has been fully implemented and represents a modern regulatory framework grounded on state of the art of cosmetic science and product technology. It is structured in regulatory modules, which include the safety assessment and the Cosmetic Product Safety Report (CPSR), Product Information File (PIF), Responsible Person (RP), label information, cosmetovigilance, substance regulations, claims, etc. The legislator''s existing goal is assurance of the safety for the ingredients and for the cosmetics products in use of consumers. In-market control is assigned to EU Member State competent authorities. The flow of information between countries is interlinked by the Cosmetic Product Notification Portal (CPNP), which is fed with the information by the demand for pre-market notification of cosmetic products and by ongoing cosmetovigilance procedures put in place with the respective provisions in the CPR. The central role in cosmetovigilance applies to the Responsible Person while the access to manufacturers and responsible persons is assured by product labeling provisions. During the workshop the provisions depicted as regulatory modules will be presented and explained with including the latest developments and research results. On the basis of the knowledge gained from this introduction, alleys towards compliance will be depicted, which will use practical examples and experiences made upon performing the necessary compliance steps before and while marketing of cosmetics products in the EU. Why should you attend: The European Union''s (EU) Cosmetics Products Regulation (CPR) 1223/2009 represents a newly re-casted piece of legislation, fully implemented since July 2013, and putting in place demanding provisions for those seeking compliance. Affected by the challenges of meeting compliance are the players in the world''s biggest cosmetic market, the EU''s internal market, as such similarly EU and non-EU manufactures of cosmetics as well as the suppliers of cosmetic ingredients requested to provide data on their chemicals. Areas Covered in the Session: • Animal Testing Ban • Roles & Responsibilities in the Supply Chain • Product Information File (PIF) • Safety Assessment • Criteria for Claims • Cosmetovigilence • Substance Regulations • Product Labeling • Borderline Industry Legislation Who will benefit: Worldwide members of the Cosmetic products industries • Managers in Cosmetics, Personal care and Consumer Health Product Industries • Managers in Ingredient Suppliers, fine Chemicals Companies • Managers in Regulatory Affairs, R&D, Formulators • Government officials, KOLs • International Sales & Marketing Representatives Speaker: Dr. Annelie Struessmann Technical Director, CONUSBAT Dr. Annelie Struessmann is the Technical & Regulatory Director with CONUSBAT Regulatory Services, a provider of internationalization compliance services for Cosmetics, Personal Care, Fine Chemicals and Borderline Industries: www.conusbat.com. In 2003, she joined the firm and, based on many years of experience gained while working with the international industry, she established the service area for regulatory affairs. Focussing on the European regulatory frameworks for cosmetic products and for chemicals (REACH), she is servicing industry clients in providing compliance strategies, safety assessments, registrations, notifications, direct representations: Cosmetic Product Responsible Person (RP), REACH Only Representative (OR). Also, Annelie publishes with various recognized journals in her area of expertise and provides workshops on a worldwide scale. Location: Zurich, Switzerland Date: June 8th & 9th, 2017 and Time: 9:00 AM to 6:00 PM Venue: Hilton Zurich Airport Address: Hohenbuhlstrasse 10, 8152 Opfikon-Glattbrugg, Switzerland. +41 44 828 50 50 Price: Price: $1,695.00 (Seminar Fee for One Delegate) Register for 5 attendees Price: $5085.00 $8,475.00 You Save: $3390.00 (40%)* Until April 30, Early Bird Price: $1,695.00 from May 1 to June 6, Regular Price: $1,895.00 Quick Contact: NetZealous DBA as GlobalCompliancePanel Phone: 1-800-447-9407 Fax: 302-288-6884 Email: support@globalcompliancepanel.com Website: http://www.globalcompliancepanel.com Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900918SEMINAR?channel=mailer&camp=Seminar&AdGroup=toxicology_Jun_2017_SEO Follow on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel

Event Type: Other Scientific Events
Organization: SMi Group
Event Title: 12th Annual ADMET 2017
Event Date or Start Date: 6/12/2017
End Date: 6/13/2017
Country: UNITED KINGDOM
State or Region: London
Meeting Website: View more information
Additional Meeting Information: The SMi Group is proud to announce the return of the 12th annual ADMET conference taking place in London on the 12th - 13th June 2017. Join our expert speaker panel at the 12th annual ADMET conference for yet another successful run! Presenting new developments, case studies and challenges in the areas of DMPK. PBPK, PKPD, in vivo/ in vitro/ in silico, transporters, hazards and safety assessment, ADMET modelling and many more! This event will explore ADMET technologies which determine properties of a drug candidate in the preclinical stage of drug discovery, structure based prediction of ADME properties, PK/PD modelling to validate drug targets and toxicity and many more. ADMET 2017 will provide a series of practical case studies delivered by leading industry experts that will provide executives with useful tools and best practices to: Predict drug design interaction Evaluate drug design interaction Use a population pharmacokinetic approach to assess DDI Review the structure based prediction of ADME properties Learn about In-Vivo drug-drug interaction Optimise human ADMET studies to assess clinically-relevant drug bioavailability Gain insight into PK/PD modelling to validate drug targets and toxicity FEATURED SPEAKERS: Ajit Narang, Senior Scientist, Genentech Andreas Reichel, VP, Head Research Pharmacokinetics, Bayer Carl Petersson, Associate Director Drug Disposition, Merck KGaA Eric Blomme, Vice President Preclinical Safety, AbbVie Handan He, Director, Section Head, Nonclinical PK/PD, Novartis Jackie Bloomer, Director, IVIVT, PTS, GSK Kiyoyuki Omoto, Scientist, Associate Research Fellow, Pfizer Kunal Taskar, Senior Investigator and Associate Fellow, GSK Laurent Salphati, Principal Scientist, Genentech Matthias Wittwer, Laboratory Head DMPK-BANP-NCPK, Bayer Na Li, Senior Staff Scientist, Corning Rob Young, Senior Scientific Investigator and GSK Associate Fellow, GSK

Event Type: Other Scientific Events
Organization: SMi Group
Event Title: 4th Immunogenicity
Event Date or Start Date: 6/12/2017
End Date: 6/13/2017
Country: UNITED KINGDOM
State or Region:
Meeting Website: View more information
Additional Meeting Information: SMi is thrilled to present the return of its 4th annual Immunogenicity conference and exhibition, taking place in London on the 12th – 13th June 2017. The immunogenicity market has seen considerable progression over recent years, with innovative developments apparent in predicting and controlling immunogenicity. However the industry is still subject to complex hurdles and challenges. This year’s conference will provide attendees with a thorough understanding of the continued need for harmonisation across risk assessments and data reporting, as well as guidance for clinical trial design. Speakers will offer deep exploration of the regulations surrounding immunogenicity testing, from the UK, Europe, and USA, giving exclusive opportunity for discussion and debate with key regulatory experts. With focus on delivering true value for all delegates in attendance, Immunogenicity 2017 will identify and solve key challenges for industry experts. Insight into aggregations, next generation biologics, novel assays, humanisation of bio-therapeutics, and improvements to accurate risk assessment will be complemented by high level case studies. CONFERENCE HIGHLIGHTS: . Guidance on UK, EU and USA regulations surrounding immunogenicity and best practice risk assessment . Targeted focus on immunogenicity; identifying, addressing and removing challenges to industry . Highlight best practice risk assessment and mitigation through high level case studies . Explore novel and innovative approaches to reducing immunogenicity . Spotlight on new technology; Humanising proteins and new biotherapeutic solutions . Personalising treatments with next generation biologic drugs

Event Type: Other Scientific Events
Organization: Toxicologist's Group of Cuban Society of Laboratory Animal Science
Event Title: CURRENT TRENDS IN GENERAL TOXICOLOGY AND FOOD SAFETY
Event Date or Start Date: 6/15/2017
End Date: 6/19/2017
Country: CUBA
State or Region: Havana
Meeting Website: View more information
Additional Meeting Information:

Dear Colleagues The group of Toxicology of the Cuban Society of Laboratory Animal Science (SCCAL) has the pleasure to invite our colleagues to the course General Toxicology and Food Safety that be hold in Havana from June 15–19, 2017 Lecturer: Dr A. Wallace Hayes PhD, DABT, FATS, FRSB, FACFE, ERT, member of SOT, Registered Toxicologist (France and EUROTOX registries) This SCCAL’s team has as gold objective to promote in our country the current concepts of the hazard and risk evaluation, inside the context of animal protection and 3Rs’ philosophy. We want to share this excellent opportunity with all our colleagues of the Region.

TOPICS
Toxicology and Risk Assessment Introduction to Toxicology Understanding the Fate of Chemicals
Chemicals Can Cause Adverse Effects
How Do We Determine if a Chemical is Harmful
Risk Assessment (Hazard Identification, Dose Response Assessment)
Risk Assessment (Exposure Assessment and Risk Characterization)
How Do We Explain to Stakeholders (Risk Communication/Risk Perception)
The Paradigm Shift (21st Century Risk Assessment)
Food Safety/Risk Management Regulatory Oversight: A USA Prospective
A Model Approach to International Food Safety: Harvard/China Food Safety Training Program

Contact: Dr. Dania Bacardi
e-mail: dania.bacardi@cigb.edu.cu


Event Type: Other Scientific Events
Organization: Institute for Scientific Communications, Inc.
Event Title: DDI-2017: 20th Anniversary International Conference on Drug-Drug Interactions
Event Date or Start Date: 6/19/2017
End Date: 6/21/2017
Country: UNITED STATES
State or Region: WA
Meeting Website: View more information
Additional Meeting Information: 20th Anniversary International Conference on Drug-Drug Interactions to be held at the HUB (Husky Union Building) on the University of Washington, Seattle, WA campus. Early Registration Ends at 11:59 PM EST May 19, 2017 NON-PROFIT ORGANIZATION SPONSORED CONFERENCE 20th Anniversary International Conference on Drug-Drug Interactions Welcome Remarks: Albert P. Li, APSciences/IVAL Opening Remarks (Ken Thummel, University of Washington; Seattle, WA) Session 1: Pioneer Symposium: Key Scientific Concepts and Technical Approaches (Chair: Albert P. Li) Biopharmaceutics Drug Disposition Classification System (BDDCS) and Drug-Drug Interactions (Leslie Z. Benet, University of California San Francisco; San Francisco, CA) Hepatic Efflux Transporters: Relevance to Drug-Drug Interactions and Drug Toxicity (Kim Brouwer, The University of North Carolina at Chapel Hill; Chapel Hill, NC) Assessment of Transporter-mediated Drug-drug Interactions: Implications of Unresolved Issues. (J Brian Houston, University of Manchester; Manchester, UK) The Prediction of Complex Transporter (uptake, efflux)/Enzyme-mediated Drug-drug Interactions be Possible Using a Proposed Physiologically-based Pharmacokinetic (PBPK) Model with In Vitro Ki Values ? (Yuichi Sugiyama, Sugiyama Laboratory, RIKEN Innovation Center, RIKEN, Research Cluster for Innovation, RIKEN; Yokohama, Japan) Mechanism-based P450 inhibition: Scientific Concepts and Relevance to Drug Development (Larry Wienkers, Amgen, Thousand Oaks, CA). Physiologically Relevant In Vitro Experimental Systems for DDI Evaluation: Novel Approaches with Human Hepatocytes (Albert P. Li, In Vitro ADMET Laboratories, Inc.; Columbia, MD) Session 2: Regulatory perspectives and clinical practice (Chair: Isabelle Ragueneau-Majlessi) 20 years of Progress in Drug-drug Interaction Evaluation: Overview of the Literature and NDA Reviews (Isabelle Ragueneau-Majlessi, University of Washington; Seattle, WA) Recommendations for Patient-Specific Drug Interaction Decision Support (Phil Hansten, University of Washington, Seattle, WA) Application of Evidence Based, Patient Specific Drug Interaction Screening (John Horn; University of Washington; Seattle, WA) Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1. (Lei Zhang, Invited; Silver Spring, MD) Cryopreserved Human Enterocytes for the Evaluation of Drug-drug and Food-drug Interactions (Albert P. Li; In Vitro ADMET Laboratories, Inc.; Columbia, MD) Session 3: Extended Clearance Concept in Drug Interactions (Chair: Jashvant Unadkat) Transport vs. metabolism: What determines the PK and PD of drugs? Insights from the Extended Clearance Model? (Jashvant Unadkat, University of Washington; Seattle, WA) The Application of the Extended Clearance Classification System in Projecting ADME Behavior and Drug-Drug Interactions in Early Discovery and Development: Industrial Perspective (Ayman El-Kattan, Pfizer, Inc.; Cambridge, MA). Predicting Transporter-mediated PK and DDIs: Building a Framework and Gaining Confidence (Manthena Varma, Pfizer, Inc.; Cambridge, MA) Session 4: Drug Metabolites as Contributors to Drug Interactions (Chair: Jan Wahlstrom) Drug Metabolites as Contributors to Clinical Drug-drug Interactions: AstraZeneca Perspectives (Ken Grime, AstraZeneca R&D; Gothenburg, Sweden) Aldehyde Oxidase Metabolite as a Perpetrator of Drug-Drug Interactions (Niresh Hariparsad; Vertex Pharmaceuticals, Boston, MA) Clinical Inhibition Caused by Metabolites (Jan Wahlstrom, Amgen, Inc.; Thousand Oaks, CA) Regulation of P450 Expression by Drug Metabolites (Nina Isoherranen, University of Washington, Seattle, WA) Session 5: Drug-transporter Interactions (Chair: Kenneth Brouwer) Evaluation and Quantitative Prediction of Renal Transporter-Mediated Drug-Drug Interactions (Bo Feng, Pfizer Inc.; Groton, CT) Inhibition of Human Hepatic Bile Acid Transporters as Contributing Factors to Drug-Induced Liver Injury (Jonathan P. Jackson, Kimberly M. Freeman, Chris Black, Robert L. St. Claire III, and Kenneth R. Brouwer. Qualyst Transporter Solutions; Durham, NC) Drug Metabolism and Transport at the Therapeutic Site of Action (Robert S. Foti, Amgen Inc.; Cambridge, MA) Application of Endogenous Probes for Early Assessing Drug-drug Interactions in Human (Yurong Lai, Bristol-Myers Squibb Company; Princeton, NJ) Session 6: Enzyme Induction and Nuclear Receptors (Chair: Jane Kenny) Using Rifampicin Data and Models to Guide Assessment of Clinically Significant CYP3A4 Induction Risk (Jane R. Kenny, Genentech; S. San Francisco, CA) Acute and Persistent Gene Expression Effects upon Neonatal Exposure to PXR and CAR Ligands (Julia Yue Cui, University of Washington; Seattle, WA) Session 7: Novel Approaches in Drug Interactions (Chair: Theunis Goosen) Novel Cytochrome P450 Reaction Phenotyping for Low-Clearance Compounds Using the Hepatocyte Relay Method (Li Di Pfizer, Inc.; Cambridge, MA) Characterization of UGT Inhibition as a Necessary and Important Strategy in Drug Development (Theunis C. Goosen, Pfizer Inc.; Groton, CT) Physiologically Based Pharmacokinetic Model of Organic Anion Transporting Polypeptide Victim Drug using Human Hepatocytes Cultured in Human Plasma Data (Jialin Mao, Genentech; S. San Francisco, CA) Physiologically Based Pharmacokinetic Model for Itraconazole Pharmacokinetics and Drug–Drug Interaction Prediction (Yuan Chen; Genentech; S. San Francisco, CA) Session 8: Biologics-Drug Interactions (Chair: Stephen Wang) DDI Potential Assessment and Challenges for Therapeutic Proteins and ADCs (Elimika Pfuma Fletcher, U.S. Food and Drug Administration; White Oak MD) Human Pharmacokinetics and Pharmacodynamics Predictions for mAbs Exhibiting Target-mediated Drug Disposition: Case Study Examples (Pratap Singh, Alexion Pharmaceuticals; New Haven, CT) DDI of Biologics, Pfizer Experience (Stephen Wang, Pfizer, Inc.; Cambridge, MA) Transporters and Antibody Drug Conjugates: A Fresh Perspective (Nagendra Chemuturi, Seattle Genetics, Bothell, WA) PLEASE VISIT WWW.IFSCOMM.ORG

Event Type: Other Scientific Events
Organization: Columbia University
Event Title: Epigenetics Boot Camp: Planning and Analyzing DNA Methylation Studies
Event Date or Start Date: 6/19/2017
End Date: 6/20/2017
Country: UNITED STATES
State or Region: NY
Meeting Website: View more information
Additional Meeting Information: A two-day intensive boot camp of seminars and hands-on analytical sessions to provide an overview of concepts, techniques, and data analysis methods utilized in human epigenetics studies.

Event Type: Other Scientific Events
Organization: Conferenceseries LLC
Event Title: 5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
Event Date or Start Date: 6/19/2017
End Date: 6/20/2017
Country: UNITED KINGDOM
State or Region: London
Meeting Website: View more information
Additional Meeting Information: Conference Series invites all the participants from all over the world to attend 5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs which is going to be held in London, UK during June-19-20,2017. Sexually transmitted diseases (STDs) are infections that can be seen when anyone having sex with someone who has the infection. The causes of STDs are bacteria, parasites and mainly by viruses like dangerous HIV/AIDS protozoans. There are more than 20 types of STDs. STDs affect both men and women, but in many cases the health problems and their cause can be seen more severe in women. If a pregnant woman has an STD, it can cause serious health problems for the baby. STD caused bacteria or parasites, can be treat with antibiotics or other medicines. For abstract submission please go through the link: http://std.conferenceseries.com/call-for-abstracts.php For Registration please go through the link: http://std.conferenceseries.com/registration.php

Event Type: Other Scientific Events
Organization: Hanson Wade
Event Title: HPAPI Summit 2017
Event Date or Start Date: 6/20/2017
End Date: 6/22/2017
Country: UNITED STATES
State or Region: MA
Meeting Website: View more information
Additional Meeting Information:

The 6th Annual HPAPI Summit will bring together perspectives from every stage of the drug development value chain, from bench to point of outsource, providing you with a unified outlook on the latest developments in highly potent manufacturing.

The increasing commercial potential of highly potent drugs is accompanied by increasingly complicated regulatory requirements and a continuing lack of effective communication within internal teams and with external contract manufacturers.

In order to address these challenges, the 6th Annual HPAPI Summit will bring together early-stage process and technical chemists, EHS and toxicology professionals and late-stage outsourcing managers to provide you with comprehensive insights into the highly potent field.

Built using insights from Genentech, Pfizer, SafeBridge, Seattle Genetics and Vertex, this three day meeting will include the very latest insights into process development and scale-up, EHS and occupational toxicology, innovative containment and cleaning solutions and optimizing outsourcing and tech transfer strategies.

 

Urls:

Brochure:


Event Type: Other Scientific Events
Organization: Conference Series Ltd
Event Title: 9th Euro-Global Summit on Toxicology and Applied Pharmacology
Event Date or Start Date: 6/22/2017
End Date: 6/24/2017
Country: FRANCE
State or Region: Paris
Meeting Website: View more information
Additional Meeting Information: 9th Euro-Global Summit on Toxicology and Applied Pharmacology en-route the insightful keynote talks, plenary sessions, oral and poster presentations is all set to stands right up as one of the best Toxicology events not be missed this year. The Scientific Committee with much precision have carved out the program so as to encompass all the evolving topics of toxicology and it’s correlation with partner disciplines such as Pharmacology, Pathology, Epigenetics, Epidemiology, Environmental Studies and Forensic Sciences and so on. Conference Venue: Hotel Novotel Marne la Vallée Noisy le Grand, Paris, France Dates: June 22-24, 2017 Email: europe@toxicologyconferences.org Agenda: http://toxicology.global-summit.com/europe/scientific-program Looking forward to meet you all in the City of Lights this June!

Event Type: Other Scientific Events
Organization: Tilesa Kenes Spain
Event Title: 13th European Congress of Clinical Pharmacology and Therapeutics - EACPT 2017
Event Date or Start Date: 6/24/2017
End Date: 6/27/2017
Country: CZECH REPUBLIC
State or Region:
Meeting Website: View more information
Additional Meeting Information: The main focus of EACPT 2017 is the role of clinical pharmacology in personalized pharmacotherapy, both a priori – pharmacogenetics – and a posteriori (therapeutic drug monitoring). The topic list includes a broad spectrum of topics that relate to Clinical Pharmacology: - Access to medicines. Innovation and sustainability of National Health Systems - Cardiovascular pharmacology and diabetes - Clinical toxicology - Clinical trials methodology - Drug development and regulatory sciences - Drug Safety and pharmacovigilance - Education - Global Health - Research Ethics - Pharmacoeconomics and health technology assessments - Inflammatory and immune based diseases and treatments - Infectious diseases. Antibiotics, antivirals, antifungals. - Neuro-psychopharmacology - Oncology - Orphan medicines - Research using Electronic Health Records. - Pharmacology of pain - Pharmacogenetics and pharmacogenomics - Pharmacokinetics, TDM, PK-PD modelling and drug interactions - Special populations

Event Type: Other Scientific Events
Organization: HansonWade
Event Title: Microbiome Drug Development Summit
Event Date or Start Date: 6/27/2017
End Date: 6/29/2017
Country: UNITED STATES
State or Region: MA
Meeting Website: View more information
Additional Meeting Information: Using insight gained from the most successful microbiome organizations across the globe, this forum helps emerging and well established companies discover, develop and deliver new generation of microbiome-based therapeutics. Microbiome Drug Development Summit will use industry case studies to develop your knowledge around four core areas of therapeutic advancement : • Scientific Activities- Translating microbiome data into a succesful health-care product • Clinical Activities- Obtaining decisive human data in a safe and timely manner • Regulatory Activities- Outlining clear regulatory paths that guarantee success • Financial Activities- Maximising shareholder value and sustaining growth Being part of Microbiome Drug Development Summit gives you the opportunity to get unprecedented access to the latest preclinical, clinical and commercial case studies from the brightest minds in biopharma and academia to turn microbiome discoveries of today into patient therapies of the future. Key Benefits of Attending: -Identify Druggable Targets for Microbiome-Therapeutic Development -Use Improved Preclinical Models for Drug Discovery -Design safe and effective Clinical Trials -Understand the expanding regulatory framework for Microbiome claims -Hear Novel Methods in Raising Investment to Accelerate Therapeutics Efforts

Event Type: Other Scientific Events
Organization: SMi Group
Event Title: 4th Allergies Conference in London
Event Date or Start Date: 7/6/2017
End Date: 7/7/2017
Country: UNITED KINGDOM
State or Region: London
Meeting Website: View more information
Additional Meeting Information: SMi is proud to present its 4th annual Allergies conference which returns to London in July 2017 to reflect on the ongoing issues and latest developments in this field. This year''s event will bring together industry leaders to discuss the latest challenges and changes in the fields of allergen immunotherapy. We will explore novel approaches to treatment, biomarkers and targeted treatments. The challenges to device development and drug delivery will be identified to deepen delegates understanding of the problems relating to these diseases, and discuss the topic of standardisation.

Event Type: Other Scientific Events
Organization: SMi Group
Event Title: 4th annual Peptides event
Event Date or Start Date: 7/6/2017
End Date: 7/7/2017
Country: UNITED KINGDOM
State or Region: London
Meeting Website: View more information
Additional Meeting Information: SMi Group's 4th Peptides Conference will return to London on 6 and 7 July at the Holiday Inn Kensington Forum. Featuring 19 presentations, 2 exclusive workshops, and a new lineup of expert speakers, the 2017 agenda will provide you two days of invaluable knowledge and networking opportunities. In the past few years, new technological advancements have influenced the growth of the global peptide therapeutics market with an increased number of peptides now in the pipeline of many biotech companies. Thus, the two-day conference is set to explore the latest peptide therapeutics advances to to improve the peptide production, reduce manufacturing costs, and allow for more accurate formulations to enhance overall drug delivery. Featured speakers include: • Alastair Lawson, Vice President, Structural Biology, UCB • Cecile Brocard, Director, Downstream Development, Boehringer Ingelheim • David Price, Senior Director, Internal Medicine, Pfizer • Craig Harris, Head of Research Synthesis, Nestlé Skin Health • Dieter Kadereit, Lab Head, Peptides and Insulins, IDD, RandD, Sanofi • Frank Thielmann, PMO and Operational Excellence Platform Leader, Biologics, Novartis • Jonathan Davis, Principal Scientist, Bristol-Myers Squibb • Marie Skovgaard, Director Medicinal Chemistry, ?Zealand Pharma • Elisabetta Bianchi, Head of Peptide Chemistry, IRBM Science Park Reasons to attend: • Gather in-depth knowledge about using LC-MS applications for peptide purification • Explore Protein-Protein Interactions through discussions on antibodies, small molecule drug discovery and peptidomimetic inhibitors • Learn more about peptide characterisation from sessions on stability, purification, synthesis • Hear about strategies for peptide half-life extension, new technologies used in therapeutic peptide development, production and manufacturing, and future trends for peptides

Event Type: Other Scientific Events
Organization: Conferenceseries LLC
Event Title: 11th International Conference on Pharmacoepidemiology and Clinical Research , July 06-08, 2017
Event Date or Start Date: 7/6/2017
End Date: 7/8/2017
Country: UNITED STATES
State or Region: MA
Meeting Website: View more information
Additional Meeting Information: Meet at the experts gathering to Join Global Scientific influencers from , Asia, Middleeast , USA (America), Europe at Pharmacoepidemiology and Clinical Research conferences happening from July 06-08, 2017, Kuala Lumpur, Malaysia. Pharm-epidemiology Congress July 06-08, 2017 at Kaula Lumpur, Malaysia is organised aiming to bring together leading academic professors, scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmacoepidemiology and Clinical research. It also provides a premier interdisciplinary pavement for Pharma, Biotech and Medical Device industries and to represent their company and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmacoepidemiology, Clinical trials and clinical research.

Event Type: SOT Sponsored Non-SOT Meeting
Organization: American College of Toxicology
Event Title: Practical Application of Toxicology in Drug Development
Event Date or Start Date: 7/17/2017
End Date: 2/24/2017
Country: UNITED KINGDOM
State or Region: Cambridge
Meeting Website: View more information
Additional Meeting Information: This course, taught by distinguished experts, provides opportunities for scientists from all parts of the world to participate in a course providing basic training in toxicology. Additionally, this course is approved by the Royal Society of Biology for the purpose of 132 CPD credits.

Event Type: Other Scientific Events
Organization: Conference Series LLC
Event Title: 10th Global Summit on Toxicology and Applied Pharmacology
Event Date or Start Date: 7/20/2017
End Date: 7/22/2017
Country: UNITED STATES
State or Region: IL
Meeting Website: View more information
Additional Meeting Information: 10th Global Summit on Toxicology and Applied Pharmacology is scheduled during July 20-22, 2017 at the most populous city Chicago, USA Toxicology 2017 The theme of the conference is Prescience of New Perceptions in the Field of Toxicology and Pharmacology.

Event Type: Other Scientific Events
Organization: Conference Series LLC
Event Title: 2nd International Conference on Food Chemistry and Hydrocolloids
Event Date or Start Date: 7/24/2017
End Date: 7/26/2017
Country: CANADA
State or Region: British Columbia
Meeting Website: View more information
Additional Meeting Information: The prestigious 2nd International Conference on Food Chemistry and Hydrocolloids to be held on July 24-26, 2017 at Vancouver, British Columbia, Canada will focus on the theme “Where food meets science: Exploring recent advances in food research and business”. We are confident that you will enjoy the Scientific Program of this upcoming Conference. This Conference will bring together practitioners, industrialists,researchers and educators from around the world who are engaged in the fields of indigenous food products, food safety, functional foods, bioactive ingredients, nutritional factors, traditional and alternative medicine, dietary management . The Conference will highlight significant developments in research and innovations in agricultural, food, nutritional, pharmaceutical and medical technologies, with an emphasis on health and wellness. The Conference will feature a series of presentations and discussions in plenary, concurrent and poster sessions, informal gatherings, and exhibitions. Website: http://foodchemistry.conferenceseries.com/ Food Chemistry 2017 Annual Conference will offer 15 panel tracks, providing you with plenty of choices for where to submit your proposal.

Event Type: Other Scientific Events
Organization: Conference Series LLC
Event Title: 2nd International Conference on Food Chemistry and Hydrocolloids
Event Date or Start Date: 7/24/2017
End Date: 7/26/2017
Country: UNITED STATES
State or Region: NV
Meeting Website: View more information
Additional Meeting Information: The prestigious 2nd International Conference on Food Chemistry and Hydrocolloids to be held on July 24-26, 2017 at Vancouver, British Columbia, Canada will focus on the theme “Where food meets science: Exploring recent advances in food research and business”. We are confident that you will enjoy the Scientific Program of this upcoming Conference. This Conference will bring together practitioners, industrialists,researchers and educators from around the world who are engaged in the fields of indigenous food products, food safety, functional foods, bioactive ingredients, nutritional factors, traditional and alternative medicine, dietary management . The Conference will highlight significant developments in research and innovations in agricultural, food, nutritional, pharmaceutical and medical technologies, with an emphasis on health and wellness. The Conference will feature a series of presentations and discussions in plenary, concurrent and poster sessions, informal gatherings, and exhibitions. Food Chemistry 2017 Annual Conference will offer 15 panel tracks, providing you with plenty of choices for where to submit your proposal. They are: Chemistry of Food Functionality and Behaviour of Hydrocolloids Food Science and Technology Food, Nutrition and Health Vitamins, Minerals and Enzymes Alcoholic and Non-Alcoholic Beverages Food Structure and Functionality Food Storage and Preservation Cereal Chemistry and Sea Food Chemistry Chemistry behind Meat and Poultry Processing Dairy Chemistry: Science, Research & Sustainability Food Waste and Recycling Processing, Fortification and Packaging of Food Herbs, Spices and Essential Oil Recent Advancement in Food Science and Food Business

Event Type: Other Scientific Events
Organization: Gordon Research Conference
Event Title: Gordon Research Conference of Drinking Water Disinfection Byproducts
Event Date or Start Date: 7/30/2017
End Date: 8/4/2017
Country: UNITED STATES
State or Region: MA
Meeting Website: View more information
Additional Meeting Information: The 2017 meeting has two main goals. The first goal is to broaden the scope beyond DBP formation within conventional drinking water plants. Disinfection represents a balance between controlling the acute risk associated with pathogens and the chronic risk linked to DBPs. The first two sessions will address this balance directly. The first session will evaluate disinfectant reactions with pathogens, recognizing that the biomolecular transformations responsible for pathogen kill are DBPs. The second session will cover tradeoffs between microbial growth and DBPs within distribution systems, the least evaluated sector of drinking water systems. The sixth section will focus on DBPs in wastewater recycling, particularly which DBPs contribute most to toxicity and how to control them. The conference will also include new arenas for DBPs, including a talk by Clorox on disinfectant design for consumer applications, and the formation of DBPs during food processing. The second goal is to move towards a solution to the DBP problem. A major strength of this conference is that it brings together engineers, chemists, toxicologists, epidemiologists and regulators, the key players for addressing this problem. Previous conferences have concluded that there is no feasible way to control pathogens without producing DBPs, so the challenge is to achieve the best balance that minimizes exposure to the DBPs driving risk. Sessions will link chemistry and toxicology to identify these toxicity drivers. Session 8 will feature discussions among chemists, exposure experts and epidemiologists about how the ideal epidemiology study should be designed to provide the evidence to link exposure to human health risks. Session 9 will conclude with presentations and a discussion regarding how to design water treatment systems that minimize toxicity drivers, including a presentation from a Dutch utility on how to avoid the use of disinfectants in drinking water distribution systems.

Event Type: Other Scientific Events
Organization: ConferenceSeries LLC
Event Title: 3rd World Congress and Exhibition on Antibiotics and Antibiotic Resistance
Event Date or Start Date: 7/31/2017
End Date: 8/1/2017
Country: ITALY
State or Region:
Meeting Website: View more information
Additional Meeting Information: Conference Series LLC invites all the participants from all over the world to attend ‘3rd World Congress and Exhibition on Antibiotics and Antibiotic Resistance' to be held on July 31-Aug 01, 2017 at Milan, Italy which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Conference Series LLC organizes 3000+ Global events in conference series every year across the globe with support from 1000+ more scientific societies and Publishes 700 Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members. Why to attend ? Antibiotics 2017 is a platform to discuss and learn about the latest advancements in the field of Antibiotics and Antibiotic Resistance as the world’s consideration turned regarding the urgency of new antibiotics as the antimicrobial resistance is growing day by day. Many developed nations and International health organizations are trying to focus of the current situation and making new policies to prevent the adverse effects of Antibiotic resistance. This 2-day conference gathers researchers, academia, labs, Drug Manufacturers, government agencies, health professionals, hospitals, young investigators, pharma and labs and presents their opinions through key notes, and case study presentations. This conference lays a platform for all the researchers working in the field of Antibiotics to know the latest developments and the current situation of the Antibiotic resistance problem.

Event Type: Other Scientific Events
Organization: Conference Series LLC
Event Title: 2nd International Conference on Physics
Event Date or Start Date: 8/28/2017
End Date: 8/30/2017
Country: BELGIUM
State or Region: Brussels
Meeting Website: View more information
Additional Meeting Information: Physics 2017 is all set to continue its legacy and be a perfect dais for a globalized networking, collaboration and welcome researchers from all across the map to share news and views regarding the advancements in the grand field of Physics. The science of physics has for its province a study of the phenomena that occur in the world of nature about us, and the endeavor to understand more fully the laws according to which these phenomena takes place. The human mind is so constituted that it is not content simply to receive impressions of the operation of great fundamental laws, as these are observed to exist in nature, Over the last 2 millennia, physics was a vicinity of physical science together with chemistry, biology, and sure branches of arithmetic; however throughout the scientific revolution within the seventeenth century, the natural sciences appeared as distinctive analysis programs. The prestigious 2nd International Conference on Physics 2017, is immensely elated to invite your gracious presence promising to offer a platform for gaining world class research experiences from Academics, Industrialists and Scientists from around the Globe.

Event Type: Other Scientific Events
Organization: Terrapinn Ltd
Event Title: World Drug Safety Congress Europe
Event Date or Start Date: 9/12/2017
End Date: 9/13/2017
Country: GERMANY
State or Region:
Meeting Website: View more information
Additional Meeting Information: The two day conference will feature a variety of case study presentations covering what''s new in drug safety, the recent EMA revisions and guidance documents and a focus on PV processes outside Europe. We will bring together 90+ experts to discuss the key challenges and solutions in drug safety this September at our 11th annual forum. Key opinion leaders will share their thoughts through presentations, round tables and panel discussions. We will have a diverse set of specially selected speakers from leading small, medium and big pharma and biotech companies, regulatory agencies, clinicians and many more to help you prepare for the future of drug safety.

Event Type: Other Scientific Events
Organization: COLABIOCLI
Event Title: XXIII Latin American Congress of Clinical Biochemistry and XI Uruguayan Congress of Clinical Chemistry
Event Date or Start Date: 9/17/2017
End Date: 9/20/2017
Country: URUGUAY
State or Region: Punta del Este
Meeting Website: View more information
Additional Meeting Information:

Event Type: SOT Sponsored Non-SOT Meeting
Organization: Asociacion Toxicologica Argentina
Event Title: IV Congreso Iberoamericano de Salud Ambiental para el Desarrollo Sustentable; XX Congreso Argentino de Toxicología y las XXXV Jornadas Argentinas Interdisciplinarias de Toxicología
Event Date or Start Date: 9/18/2017
End Date: 9/23/2017
Country: ARGENTINA
State or Region: Argentina
Meeting Website: View more information
Additional Meeting Information: Pre-congress activities: Doctoral Course

Event Type: Other Scientific Events
Organization: Safety Pharmacology Society (SPS)
Event Title: 2017 Safety Pharmacology Society Annual Meeting
Event Date or Start Date: 9/24/2017
End Date: 9/27/2017
Country: GERMANY
State or Region: Berlin
Meeting Website: View more information
Additional Meeting Information: On behalf of the Safety Pharmacology Society (SPS), we would like to invite you and your colleagues to attend the 2017 SPS Annual Meeting, September 24–27, 2017, at the Maritim Hotel in the Capital City of Germany, Berlin. Over the last few months, the 2017 Program Committee has been hard at work organizing a scientific program that includes topics of interest to SPS Members and colleagues. The 2017 Scientific Program features a diverse range of scientific sessions organized into two themed tracks and covering issues such as Addressing Safety in Oncology, Translational Safety Pharmacology, Suicidality, New Modalities and New Biological Entities, Disease Models/Personalized Medicine, Microphysiological Systems - New Technologies, In Silico Modeling, Right Species-Right Time, Changing Regulatory Environment and much more! This will ensure attendees can stay abreast of new content and developments in key areas of interest. The meeting also offers a broad Continuing Education program both on an introductory level as well as advanced courses for the expert. A preliminary program outline is now available on the 2017 Meeting website. We will also be holding the 2017 certification exam for the Diplomate in Safety Pharmacology, and invite all interested SPS members to consider sitting the exam this year. In an effort to support attendance from our younger colleagues, please note that there are expanded opportunities for Student and Jr. Investigator Travel Awards. Also, please consider submitting an abstract for presentation as a poster. From these submissions a variety will also be selected for short oral communications. The deadline to submit an abstract for presentation is June 15, 2017. We also would like to highlight our Exhibit Hall, which will feature over 40 vendors offering direct access to CROs, as well as a variety of service and technology providers exhibiting the latest trends, technology, and developments relevant to the field.

Event Type: Other Scientific Events
Organization: Pulsus Group
Event Title: International Conference on Osteoporosis
Event Date or Start Date: 9/28/2017
End Date: 9/29/2017
Country: SPAIN
State or Region:
Meeting Website: View more information
Additional Meeting Information: Pulsus Group invites you to attend “The International Conference on Osteoporosis” that is to be held during September 28-29, 2017 at Madrid, Spain providing an international platform for physicians, rheumatologists, young researchers, students, physiatrists, orthopedists, and geriatricians to share the information and scientific progress in treating osteoporosis. This conference concentrates on the newest and advanced innovations in all the areas of osteoporosis research. This conference highlights the theme, “Osteoporosis as a primary health concern” that emphasizes on quality health of the world population. The conference includes osteoporosis workshops, symposiums, special keynote sessions conducted by eminent and notable speakers who surpass in the field of orthopaedics that include the topics pathophysiology and causes, clinical diagnosis, risk factor, symptoms, complications and prevention, endocrinology in osteoporosis, treatment, pharmaceutical and prosthetics market, research and development, alternative treatment and advancements in surgeries and diagnostic tools. This International Conference on osteoporosis additionally encourages the active participation of young student researchers since we are hosting Poster Award Competition and Young research Forum at the conference venue.

Event Type: Other Scientific Events
Organization: Terrapinn
Event Title: World Vaccine Congress 2017
Event Date or Start Date: 10/10/2017
End Date: 10/12/2017
Country: SPAIN
State or Region: Barcelona
Meeting Website: View more information
Additional Meeting Information:

Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, at the 18th annual World Vaccine Congress we have content, networking and potential partners for you.

By bringing experts from the whole value chain under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture.

Take just three days out of the office to meet with 450+ potential customers who need to find solutions to challenges around the commercial and scientific issues in manufacturing, trials, strategy, regulation, veterinary, immune profiling, respiratory, therapeutic and emerging diseases vaccines.

The World Vaccine Congress Europe is a place where collaborations are founded and scientific innovations are sparked.


Event Type: Other Scientific Events
Organization: conference series llc
Event Title: 15th World Medical Nanotechnology Congress & Expo
Event Date or Start Date: 10/18/2017
End Date: 10/19/2017
Country: JAPAN
State or Region: osaka
Meeting Website: View more information
Additional Meeting Information: Global Experts Meeting on “15th World Medical Nanotechnology Congress & Expo” is to be held in Osaka, Japan during October 18, 19 of 2017 Organized by Conference series LLC. It will bring together world-class professors, scientists, academic scholars, and doctors, engineers, students, delegates to discuss the current developments, renewable materials and New Medical technologies on in the field of Nanotechnology from all around the world. Link - http://medicalnanotechnology.conferenceseries.com/

Event Type: Other Scientific Events
Organization: Conference Series LLC
Event Title: 3rd International Conference on Transcriptomics
Event Date or Start Date: 10/30/2017
End Date: 11/1/2017
Country: THAILAND
State or Region: Bangkok
Meeting Website: View more information
Additional Meeting Information: http://transcriptomics.conferenceseries.com/registration.php

Event Type: Other Scientific Events
Organization: Terrapinn ltd
Event Title: BioData World Congress
Event Date or Start Date: 11/1/2017
End Date: 11/3/2017
Country: UNITED KINGDOM
State or Region:
Meeting Website: View more information
Additional Meeting Information: Held with the support of the Sanger Institute, the EBI the Global Alliance for Genomics and Health and The Pistoia Alliance, BioData World Congress aims to showcase innovation, demonstrate success and break through the obstacles and barriers to ensure that the innovations in genomics get to the patient with speed and efficiency. With a mixture of keynote sessions, roundtables, focused work tracks, site visits, product demonstrations and networking parties, this event will push the boundaries in order to realise the power of big data in precision medicine.

Event Type: Other Scientific Events
Organization: RauCon business development
Event Title: euroPLX 65 London Pharma Partnering
Event Date or Start Date: 11/27/2017
End Date: 11/28/2017
Country: UNITED KINGDOM
State or Region: London
Meeting Website: View more information
Additional Meeting Information:

Just business, no lectures, no presentation. The most effective and most often held pharma partnering event around since more than 24 years, will now be held for the 65th time.

Fly in, do business, fly out. Leave the plane and check in at the Sofitel London Heathrow within 40 minutes - via free inter-terminal transfer! Join the most effective end-of-year partnering event at the Heathrow Airport!

One of the most advanced online interaction and matchmaking systems since well over 22 years provides 25 to 29 pre-arranged business meetings per attending company. Interaction between confirmed registrants starts right after registration and during the matchmaking run-up to a two-days summit of targeted, pre-scheduled one-on-one meetings of top executives of drug developing, producing or marketing companies from all over the world.

URL:
Booking:


Event Type: Webinars
Organization: Future Publishing Solutions Ltd
Event Title: South African Pharmaceutical Exhibition (SAPHEX)
Event Date or Start Date: 11/28/2017
End Date: 11/29/2017
Country: SOUTH AFRICA
State or Region:
Meeting Website: View more information
Additional Meeting Information: Saphex is rapidly establishing itself as the most strategic industry event in the South African region that brings together all major stakeholders – industry leaders, policy-makers, regulators, academics, investors, scientists and patient representatives, to tackle the most pressing issues the industry is facing. With over 2000 visitors expected at Saphex 2017, there will be ample opportunity for you to connect and establish relationships with fellow professionals from the pharmaceutical industry. We are also anticipating over 130 exhibitors and over 100 countries represented at the event. The event will incorporate an exhibition and a conference, delivering business contacts and forging strategic alliances in combination with the knowledge and information that you will need to win in the South African pharmaceutical sector. Saphex will be held under the theme, ''Continuing development of the South African Pharmaceutical Industry: Forging ideas for the future composition of the sector''. Aiming to explore the current composition of the industry in South Africa, and inviting several experts in their respective fields to give their opinion on where the future of the market may lead. The approach that companies pursue will hinge upon their individual goals. Inevitably companies will need to decide how to satisfy contending stakeholder demands while pursuing sustainable growth in a competitive market.

Event Type: Other Scientific Events
Organization: Euroexpo Exhibitions & Congress Development GmbH
Event Title: APTEKA 2017
Event Date or Start Date: 12/4/2017
End Date: 12/7/2017
Country: RUSSIA
State or Region: Moscow
Meeting Website: View more information
Additional Meeting Information: Over the years APTEKA exhibition has become the leading event in Russia that brings together the pharmaceutical industry experts, manufacturers and distributors of drugs and medical products, representatives of retail and chain pharmacies, medical practitioners, drug developers and healthcare authorities. An international medical and pharmaceutical business forum is also held at APTEKA, conveying the latest reforms happening. Mission of APTEKA 2017: Promotion of the pharmaceutical industry development, information about new products, achievements, innovative projects and events, improvement of pharmaceutical ingredients and drugs manufacturing. APTEKA exhibition will be held within the International Scientific and Practical Forum RUSSIAN HEALTHCARE WEEK that comprises a series of exhibition and convention events dedicated to medicine and pharmaceutics, including Zdravookhraneniye exhibition. MARKET INFORMATION Volume of pharmaceutical USD 29 billion market in Russia (2016). Volume of imported medical preparations (total worth of sales) 70%. TRADITIONAL MEDICAL SYSTEMS OF THE WORLD 2017 3rd International Forum Every year APTEKA trade fair hosts the International Medical and Pharmaceutical Business Forum. The Key Opinion Leaders of the Industry present the latest innovations and techniques in their fields.

Event Type: SOT Sponsored Non-SOT Meeting
Organization: IUTOX - Serbian SOT
Event Title: 10th CTDC Meeting
Event Date or Start Date: 4/18/2018
End Date: 4/21/2018
Country: SERBIA
State or Region:
Meeting Website: View more information
Additional Meeting Information: The International Union of Toxicology (IUTOX) and the Serbian Society of Toxicology (SETOX) are pleased to announce that the 10th Congress of Toxicology in Developing Countries (CTDC 10) and the 12th Serbian Congress of Toxicology will be held on April 18-21, 2018, in Belgrade, Serbia. The call for scientific proposals for CTDC10 congress is underway and we need your contribution. Our theme is “From Science to Human and Environmental Health Benefits”. Please read the attached Call for Scientific Proposals and submit your scientific proposal using the attached form to ctdc10@pharmacy.bg.ac.rs by February 20, 2017.

Event Type: SOT Sponsored Non-SOT Meeting
Organization: IUTOX and the Society of Toxicology, USA
Event Title: ICT XV Meeting
Event Date or Start Date: 7/15/2019
End Date: 7/18/2019
Country: UNITED STATES
State or Region: HI
Meeting Website: View more information
Additional Meeting Information: Aloha! IUTOX and the Society of Toxicology, USA (SOT) are pleased to announce the next triennial International Congress of Toxicology (ICT) to be held July 15–18, 2019, at the Hawaii Convention Center in Honolulu, Hawaii, USA. This will be the first ICT in the United States since ICT VI in 1995.